US20180150614A1 - Interactive patient guidance for medical devices - Google Patents
Interactive patient guidance for medical devices Download PDFInfo
- Publication number
- US20180150614A1 US20180150614A1 US15/362,642 US201615362642A US2018150614A1 US 20180150614 A1 US20180150614 A1 US 20180150614A1 US 201615362642 A US201615362642 A US 201615362642A US 2018150614 A1 US2018150614 A1 US 2018150614A1
- Authority
- US
- United States
- Prior art keywords
- user interface
- user
- guidance
- display
- infusion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000002452 interceptive effect Effects 0.000 title abstract description 26
- 238000001802 infusion Methods 0.000 claims abstract description 209
- 238000000034 method Methods 0.000 claims abstract description 57
- 230000004044 response Effects 0.000 claims abstract description 31
- 239000012530 fluid Substances 0.000 claims description 62
- 238000004891 communication Methods 0.000 claims description 39
- 230000009471 action Effects 0.000 claims description 32
- 238000012545 processing Methods 0.000 claims description 13
- 230000004962 physiological condition Effects 0.000 claims description 10
- 238000013500 data storage Methods 0.000 claims description 9
- 230000008569 process Effects 0.000 description 30
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 24
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 21
- 239000008103 glucose Substances 0.000 description 21
- 229940079593 drug Drugs 0.000 description 13
- 239000003814 drug Substances 0.000 description 13
- 102000004877 Insulin Human genes 0.000 description 12
- 108090001061 Insulin Proteins 0.000 description 12
- 230000000875 corresponding effect Effects 0.000 description 12
- 229940125396 insulin Drugs 0.000 description 12
- 230000008859 change Effects 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 238000006073 displacement reaction Methods 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 2
- 238000011394 anticancer treatment Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000009920 chelation Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 229940124583 pain medication Drugs 0.000 description 2
- 208000002815 pulmonary hypertension Diseases 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 235000021074 carbohydrate intake Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000006362 insulin response pathway Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000006855 networking Effects 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- G06F19/3468—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
-
- G06F19/3406—
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3303—Using a biosensor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3561—Range local, e.g. within room or hospital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/201—Glucose concentration
Definitions
- Embodiments of the subject matter described herein relate generally to medical devices, and more particularly, embodiments of the subject matter relate to facilitating patient operation of a medical device.
- Infusion pump devices and systems are relatively well known in the medical arts, for use in delivering or dispensing an agent, such as insulin or another prescribed medication, to a patient.
- a typical infusion pump includes a pump drive system which typically includes a small motor and drive train components that convert rotational motor motion to a translational displacement of a plunger (or stopper) in a reservoir that delivers medication from the reservoir to the body of a user via a fluid path created between the reservoir and the body of a user.
- Use of infusion pump therapy has been increasing, especially for delivering insulin for diabetics.
- Control schemes have been developed that allow insulin infusion pumps to monitor and regulate a user's blood glucose level in a substantially continuous and autonomous manner.
- regulating blood glucose level is still complicated by variations in a user's individual insulin response and daily activities (e.g., exercise, carbohydrate consumption, bolus administration, and the like) in conjunction with variations associated with the devices or components used to implement continuous glucose monitoring and related controls, and potentially other factors that may contribute to variations, uncertainty, or otherwise impair accuracy or reliability. Since many of the variables influencing glucose regulation and control may often be dynamically or periodically changing, some user involvement with the infusion pump may be desirable to achieve the desired performance and outcomes.
- Modern devices may incorporate or support any number of potential features as well as utilizing various user interface(s), which may be unique to a particular device. Therefore, it is desirable for device manufacturers to provide additional consumer education.
- product manuals or guides documenting the various aspects of the device were provided. For some users, printed documentation can be disfavored and neglected.
- medical devices may not be as equipped as other computer devices for providing consumer education features electronically. Though customer service or other manufacturer support may be available by phone or email, many users tend to find invoking such services to be time consuming and inconvenient. Accordingly, there is a need to provide consumer education in a manner that is simple, convenient, and efficient to enable maximizing device performance for optimal patient outcomes.
- An exemplary method of interactively providing guidance facilitating operation of a medical device involves identifying, at a computing device communicatively coupled to the medical device, a user objective associated with the medical device, obtaining, at the computing device from the medical device, user interface status information corresponding to a current state of a user interface of the medical device, and providing, on a display associated with the computing device, guidance information influenced by the user interface status information and the user objective. Subsequently, updated user interface status information for the infusion device responsive to a user input with respect to the infusion device may be provided to the computing device, with the guidance information being dynamically updated in response to the updated status information.
- an apparatus for a medical device includes a display to provide one or more graphical user interface displays, a user interface element to receive a user input, a data storage element to maintain settings information, a communications interface communicatively coupled to a network, and control module coupled to the display, the user interface element, the data storage element, and the communications interface.
- the control module is configurable to transmit the settings information and status information characterizing a state of the display to an auxiliary device via the network, and in response to the user input, automatically push updated status information characterizing an updated state of the display responsive to the user input to the auxiliary device via the network.
- Another embodiment of a method of facilitating operation of an infusion device to deliver a fluid influencing a physiological condition to a body of a user involves identifying, at a computing device communicatively coupled to the infusion device, an objective associated with the infusion device. obtaining, at the computing device from the infusion device via a network, current user interface status information for the infusion device, and generating, at the computing device, a guidance graphical user interface display comprising a sequence of one or more user actions with respect to the infusion device for achieving the objective based at least in part on the current user interface status information.
- FIG. 1 depicts an exemplary embodiment of a patient guidance system
- FIG. 2 is a flow diagram of an exemplary interactive guidance process suitable for use with the patient guidance system of FIG. 1 in one or more exemplary embodiments;
- FIGS. 3-8 depict a sequence of graphical user interface displays that may be presented in conjunction with the interactive guidance process of FIG. 2 in one embodiment
- FIGS. 9-10 depict another sequence of graphical user interface displays that may be presented in conjunction with the interactive guidance process of FIG. 2 in another embodiment
- FIG. 11 depicts an exemplary embodiment of an infusion system
- FIG. 12 depicts a plan view of an exemplary embodiment of a fluid infusion device suitable for use in the infusion system of FIG. 11 ;
- FIG. 13 is an exploded perspective view of the fluid infusion device of FIG. 12 ;
- FIG. 14 is a cross-sectional view of the fluid infusion device of FIGS. 12-13 as viewed along line 14 - 14 in FIG. 13 when assembled with a reservoir inserted in the infusion device;
- FIG. 15 is a block diagram of an exemplary medical device suitable for use in conjunction with the interactive guidance process of FIG. 2 in accordance with one or more exemplary embodiments.
- Exemplary embodiments of the subject matter described herein are implemented in conjunction with medical devices, such as portable electronic medical devices. Although many different applications are possible, the following description focuses on embodiments that incorporate a fluid infusion device (or infusion pump) as part of an infusion system deployment. For the sake of brevity, conventional techniques related to infusion system operation, insulin pump and/or infusion set operation, and other functional aspects of the systems (and the individual operating components of the systems) may not be described in detail here. Examples of infusion pumps may be of the type described in, but not limited to, U.S. Pat. Nos.
- a fluid infusion device includes a motor or other actuation arrangement that is operable to linearly displace a plunger (or stopper) of a reservoir provided within the fluid infusion device to deliver a dosage of fluid, such as insulin, to the body of a user.
- Dosage commands that govern operation of the motor may be generated in an automated manner in accordance with the delivery control scheme associated with a particular operating mode, and the dosage commands may be generated in a manner that is influenced by a current (or most recent) measurement of a physiological condition in the body of the user.
- dosage commands may be generated based on a difference between a current (or most recent) measurement of the interstitial fluid glucose level in the body of the user and a target (or reference) glucose value.
- the rate of infusion may vary as the difference between a current measurement value and the target measurement value fluctuates.
- the subject matter is described herein in the context of the infused fluid being insulin for regulating a glucose level of a user (or patient); however, it should be appreciated that many other fluids may be administered through infusion, and the subject matter described herein is not necessarily limited to use with insulin.
- Exemplary embodiments described herein generally relate to systems and methods of interactively providing guidance information pertaining to a medical device for review or action by a user on an auxiliary device, such as a computer, a smartphone, or the like, to help facilitate the configuration or operation of various features of a medical device.
- the auxiliary device identifies or otherwise determines the user's objective associated with the medical device, such as, for example, what the user wants to accomplish using the medical device, what aspect of the medical device the user has questions about, or the like.
- the auxiliary device also obtains, from the medical device, status information that characterizes, describes, or otherwise corresponds to a current state of a user interface of the medical device.
- the user interface status information may indicate a current graphical user interface (GUI) displayed on a display of the medical device and a current selection or position of a user input element on the display.
- GUI graphical user interface
- the guidance information indicative of the user actions for accomplishing the user's objective is determined and presented or otherwise provided on a display associated with the auxiliary device for review by the user.
- the user may concurrently view the guidance information for accomplishing the objective presented on the auxiliary device while interacting with the medical device in accordance with the guidance information.
- the auxiliary device and the medical device are paired over a communications network, so that the medical device may upload, push, or otherwise transmit updated user interface status information to the auxiliary device substantially in real-time in response to a user input or other interaction with the medical device.
- the guidance information presented on the auxiliary device is dynamically updated to reflect how the user input influenced the user actions for accomplishing the user's objective from the updated user interface state.
- the guidance information on the auxiliary device may be dynamically updated substantially concurrently, allowing the user to move back and forth across displays seamlessly.
- the auxiliary device also obtains operational settings or other device configuration information from the medical device to provide guidance information consistent with the current device setup or other user- or patient-specific configurations. For example, if the user's objective is to administer a bolus using the infusion device, the operational settings information obtained by the auxiliary device may indicate that a bolus wizard feature of the infusion device has not been setup, in which case the guidance information may provide instructions for how to configure or setup the bolus wizard. Conversely, when the operational settings information indicates the bolus wizard feature has been setup and is currently enabled, the guidance information may provide instructions for utilizing the bolus wizard.
- the guidance information may instruct the user for configuring and enabling such features.
- the provided guidance information does not pertain to device features or operating modes that the user has not enabled, configured, or otherwise activated.
- the user may be provided only with guidance information pertinent to both the current device configuration and the user's objective. As such, providing potentially non-pertinent or non-actionable information is avoided, which improves the user experience.
- FIG. 1 depicts an exemplary embodiment of a patient guidance system 100 .
- the patient guidance system 100 includes an infusion device 102 communicatively coupled to an auxiliary device 106 via a network 110 .
- the auxiliary device 106 supports an application 108 that generates and provides guidance information on a display associated with the auxiliary device 108 that includes instructions or other indication of user actions for accomplishing an objective associated with the infusion device 102 based on that objective and the current user interface status for the infusion device 102 received via the network 110 .
- the infusion device 102 is also communicatively coupled to a sensing arrangement 104 to obtain measurement data indicative of a physiological condition in the body of a patient, such as sensor glucose measurement values.
- the infusion device 102 operates autonomously to regulate the patient's glucose level based on the sensor glucose measurement values received from the sensing arrangement 104 .
- the auxiliary device 106 represents an electronic device capable of communicating with the infusion device 102 via communications network 110 .
- the network 110 is realized as a Bluetooth network, a ZigBee network, a wireless local area network (WLAN), or another suitable personal area network or local area network (LAN). That said, in other embodiments, the infusion device 102 and the auxiliary device 106 may communicate via a direct communications interface, such as a wire, cable, infrared, or some other short range communications medium.
- the auxiliary device 106 may be realized as any sort of electronic device capable of communicating with the infusion device 102 via network 110 , such as a mobile telephone, a smartphone, a laptop or notebook computer, a tablet computer, a desktop computer, a personal digital assistant, or the like.
- the auxiliary device 106 may alternatively be referred to herein as a client device.
- the client device 106 includes or is coupled to a display device, such as a monitor, screen, or another conventional electronic display, capable of graphically presenting data and/or information.
- the client device 106 also includes or is otherwise associated with a user input device, such as a keyboard, a mouse, a touchscreen, or the like, capable of receiving input data and/or other information from the user of the client device 106 .
- a user manipulates the client device 106 to execute a client application 108 that communicates with the infusion device 102 via the network 110 using a networking protocol.
- the client application 108 supports establishing a communications session with the infusion device 102 on the network 110 and receiving data and/or information from the infusion device 102 via the communications session.
- the infusion device 102 may execute or otherwise implement a corresponding application or process that supports establishing the communications session with the client application 108 .
- the client application 108 generally represents a software module or another feature that is generated or otherwise implemented by the client device 106 to support the processes described herein.
- the client device 106 includes a processing system and a data storage element (or memory) capable of storing programming instructions for execution by the processing system, that, when read and executed, cause processing system to create, generate, or otherwise facilitate the client application 108 and perform or otherwise support the processes, tasks, operations, and/or functions described herein.
- the processing system may be implemented using any suitable processing system and/or device, such as, for example, one or more processors, central processing units (CPUs), controllers, microprocessors, microcontrollers, processing cores and/or other hardware computing resources configured to support the operation of the processing system described herein.
- the data storage element or memory may be realized as a random access memory (RAM), read only memory (ROM), flash memory, magnetic or optical mass storage, or any other suitable non-transitory short or long term data storage or other computer-readable media, and/or any suitable combination thereof.
- RAM random access memory
- ROM read only memory
- flash memory magnetic or optical mass storage, or any other suitable non-transitory short or long term data storage or other computer-readable media, and/or any suitable combination thereof.
- the infusion device 102 and the client device 106 establish an association (or pairing) with one another over the network 110 to support subsequently establishing a peer-to-peer communication session between the infusion device 102 and the client device 106 via the network 110 .
- the network 110 is realized as a Bluetooth network, wherein the infusion device 102 and the client device 106 are paired with one another (e.g., by obtaining and storing network identification information for one another) by performing a discovery procedure or another suitable pairing procedure.
- the pairing information obtained during the discovery procedure allows either of the infusion device 102 or the client device 106 to initiate the establishment of a secure peer-to-peer communication session via the network 110 .
- the client application 108 is configured to store or otherwise maintain an address and/or other identification information for a remote device 114 on another network 112 .
- the second network 112 may be physically and/or logically distinct from the network 110 , such as, for example, the Internet, a cellular network, a wide area network (WAN), or the like.
- the remote device 114 generally represents a computing device that includes or otherwise implements a support application 116 configured to receive or otherwise obtain the current user interface status information for the infusion device 102 and the current user objective from the client application 108 and present the information to another user operating the remote device 114 for analysis.
- the remote device 114 may be utilized by customer service personnel to provide customer support in the event the patient or user of the client device 108 is having difficulty accomplishing his or her objective with respect to the infusion device 102 , as described in greater detail below in the context of FIG. 2 .
- the remote device 114 may reside at a location that is physically distinct and/or separate from the infusion device 102 , such as, for example, at a facility that is owned and/or operated by or otherwise affiliated with a manufacturer of the infusion device 102 .
- FIG. 1 depicts a simplified representation of a patient guidance system 100 for purposes of explanation and is not intended to limit the subject matter described herein in any way.
- one or more of the devices 102 , 104 , 106 , 114 may be absent from the patient guidance system 100 .
- FIG. 1 depicts a single sensing arrangement 104
- embodiments of the patient guidance system 100 may include multiple different sensing arrangements, which may be configured to sense, measure, or otherwise quantify any number of conditions or characteristics.
- multiple instances of a glucose sensing arrangement 104 may be deployed for redundancy or other purposes (e.g., averaging or other statistical operations).
- additional sensing arrangements 104 may be deployed to measure different physiological conditions of the patient, such as, for example, the patient's heart rate, oxygen levels, or the like.
- FIG. 2 depicts an exemplary interactive guidance process 200 suitable for implementation by a patient guidance system to provide guidance to a patient or user to facilitate desired operation of a medical device, such as infusion device 102 .
- the various tasks performed in connection with the interactive guidance process 200 may be performed by hardware, firmware, software executed by processing circuitry, or any combination thereof.
- the following description refers to elements mentioned above in connection with FIG. 1 .
- portions of the interactive guidance process 200 may be performed by different elements of the patient guidance system 100 , such as, for example, the infusion device 102 , the sensing arrangement 104 , the client device 106 , the client application 108 , the remote device 114 and/or the support application 116 .
- the interactive guidance process 200 may include any number of additional or alternative tasks, the tasks need not be performed in the illustrated order and/or the tasks may be performed concurrently, and/or the interactive guidance process 200 may be incorporated into a more comprehensive procedure or process having additional functionality not described in detail herein. Moreover, one or more of the tasks shown and described in the context of FIG. 2 could be omitted from a practical embodiment of the interactive guidance process 200 as long as the intended overall functionality remains intact.
- the interactive guidance process 200 begins by determining or otherwise identifying an objective associated with operation of the medical device (task 202 ).
- the client application 108 identifies what the patient or user of the client device 106 is trying to accomplish or achieve using the infusion device 102 or what feature or aspect of the infusion device 102 is of interest to the patient.
- the client application 108 may generate or otherwise provide a GUI display that allows the patient to select, input, or otherwise indicate what the patient's objective is.
- the client application 108 generates a list of selectable GUI elements, where each of the GUI elements corresponds to a different objective, as described in greater detail below in the context of FIG. 3 .
- the client application 108 may determine what the patient's objective is based on the current state of the infusion device 102 . For example, when the patient manipulates the client device 106 to initiate or open the client application 108 , the client application 108 may establish a communications session with the infusion device 102 via the network 110 , obtain information characterizing the current device state from the infusion device 102 via the network 110 , and then determine a likely patient objective based on the current device state. In this regard, if there is an active alert or notification presented to generated by the infusion device 102 , the client application 108 may determine the patient's objective is to resolve or understand the current alert or notification.
- the client application 108 may determine the patient's objective is to enable or resume delivery. It should be noted that are numerous different potential device statuses and corresponding objectives that may be determined based thereon, and the subject matter described herein is not limited to any particular example described herein.
- the client application 108 may determine what the patient's objective is based on a GUI element selected within the client application 108 .
- the client application 108 may include a selectable GUI element for activating a help feature, and thereby indicate a patient objective indicative of a desire to obtain explanatory information or other help understanding the GUI display currently presented by the infusion device 102 .
- the interactive guidance process 200 continues by obtaining status information indicative of the current state of the display on the medical device, the current state of the user input element(s) associated with the medical device, and the current operational settings or configuration of the medical device (tasks 204 , 206 , 208 ).
- the client application 108 receives or otherwise obtains, from the infusion device 102 via the network 110 , information or data that indicates, identifies, or otherwise describes the current screen, menu, or other GUI display presented on the infusion device 102 .
- the client application 108 also receives or obtains information that indicates or identifies the state of a user input selection (or a mouse, icon, or other graphical representation thereof) on the screen, menu, or other GUI display presented on the infusion device 102 .
- the client application 108 may also obtain information pertaining to preceding user inputs or the sequence of user input selections made prior to performing the interactive guidance process 200 . Additionally, the client application 108 obtains settings or configuration data stored or otherwise maintained onboard the infusion device 102 pertaining to the various modes, features, or other patient-specific or patient-configurable operations supported by the infusion device 102 .
- the current device settings information may indicate the modes or features supported by the infusion device 102 that have been enabled, activated, or configured, which modes or features supported by the infusion device 102 that have been disabled or deactivated, which patient-specific control parameters, variables, or other patient settings for which values have been defined, entered or otherwise provided, and which patient-specific control parameters, variables, or other patient settings for which no values are maintained by the infusion device 102 .
- the interactive guidance process 200 Based on the user's objective, the current user interface status, and the current device settings, the interactive guidance process 200 generates or otherwise provides a guidance GUI display on the auxiliary device that indicates or otherwise explains how the user can achieve the objective given the current user interface status and the current device settings (task 210 ).
- the guidance GUI display on the client device 106 may provide one or more instructions or actions that the user can take from the current GUI display on the infusion device 102 given the current state of the user input(s) associated with the infusion device 102 and the current infusion device settings.
- the guidance information provided by the application 108 on the client device 106 is consistent with (or context-sensitive to) both the current infusion device operational settings and the current patient-specific settings maintained by the infusion device 102 , while also being context-sensitive with respect to the user interfaces of the infusion device 102 to reflect the current GUI display on the infusion device 102 and current state of user interaction with respect to that GUI display on the infusion device 102 .
- the guidance information is not incompatible or inconsistent with current settings maintained by the infusion device 102 , and is also not incompatible or inconsistent with the current user interface status of the infusion device 102 .
- the interactive guidance process 200 After initially providing guidance information, the interactive guidance process 200 continues by monitoring or otherwise waiting for changes in the user interface state of the medical device, an in response to a change in the user interface state, the interactive guidance process 200 receives or otherwise obtains updated user interface status information from the medical device and dynamically updates the guidance information to reflect the change in user interface state (tasks 210 , 212 , 214 ).
- the interactive guidance process 200 receives or otherwise obtains updated user interface status information from the medical device and dynamically updates the guidance information to reflect the change in user interface state (tasks 210 , 212 , 214 ).
- the interactive guidance process 200 receives or otherwise obtains updated user interface status information from the medical device and dynamically updates the guidance information to reflect the change in user interface state (tasks 210 , 212 , 214 ).
- the corresponding updated status information characterizing the state or location of the user input element(s) associated with the infusion device 102 as well as the current display state of the infusion device 102 is automatically provided to the client application 108
- a process or application on the infusion device 102 that supports the communication session with the client application 108 automatically pushes updated user interface status information to the client application 108 whenever a new user input is received or whenever the GUI display on the infusion device 102 changes.
- the client application 108 automatically obtains the updated user interface status information substantially in real-time and dynamically refreshes or updates the GUI display on the client device 106 to reflect the current situation on the infusion device 102 , for example, by providing updated instructions or actions that the user can take to achieve the original objective (e.g., task 202 ) from the updated GUI display on the infusion device 102 in response to intervening user input(s) associated with the infusion device 102 after the preceding guidance GUI display was originally provided.
- the original objective e.g., task 202
- the loop defined by tasks 210 , 212 , 214 and 216 repeats to dynamically update the guidance GUI display on the client device 106 substantially in real-time as the patient or user interacts with the infusion device 102 until the original objective is accomplished.
- the client application 108 may update the GUI display on the client device 106 to reflect the objective being achieved or to revert back to a default or initial GUI display associated with the client application 108 (e.g., a home page or other landing page).
- the interactive guidance process 200 may identify or otherwise determine when remote assistance or other supplementary feedback is desired by the user, and in response, transmits, uploads, or otherwise provides the user objective and status information to a remote device for analysis (tasks 218 , 220 ).
- the guidance GUI display provided by the client application 108 on the client device 106 may include a GUI element that is selectable or otherwise manipulable to initiate a customer support communications session with a customer support application 118 on a remote device 114 .
- the client application 108 may store or otherwise maintain an address and/or other identification information for the remote device 116 on the second network 112 to support establishing a secure communications session over the network 112 for uploading or otherwise transmitting information characterizing the current user objective, the current state of the display on the infusion device 102 , the current state of the user input element(s) associated with the infusion device 102 , and the current settings or configuration of the infusion device 102 .
- the client application 108 may be adapted to allow the user of the client device 106 to input or otherwise provide questions that the user would like answered or otherwise explain the user's perception of the current situation and/or what the user would like to accomplish.
- the client application 108 may include a GUI element (e.g., a button or the like) that enables the user of the client device 106 to initiate a telephone call, a video call, or the like with a user of the remote device 116 .
- a GUI element e.g., a button or the like
- the customer support application 118 on the remote device 116 is configured to generate or otherwise provide a GUI display on the remote device 116 that allows a remote user (e.g., a customer service specialist or the like) to review and analyze the current situation at the infusion device 102 and provide corresponding feedback back to the user of the client device 106 to facilitate achieving the user's objective with respect to the infusion device 102 .
- a remote user e.g., a customer service specialist or the like
- the user of the remote device 116 may input or otherwise provide a textual explanation or feedback regarding the current status at the infusion device 102 relative to the current user objective via the support application 118 and then select or otherwise manipulate a GUI element of the support application 118 to transmit the feedback back to the client application 108 via the communications session over the network 112 .
- the interactive guidance process 200 may update the guidance GUI display based on feedback received from the remote device (task 222 ).
- the client application 108 may generate or otherwise provide the feedback received from the support application 116 on the guidance GUI display in lieu of the previously presented guidance information or on a separate GUI display (e.g., a pop-up window).
- the support session may be dynamically updated in a similar manner as described above in the context of the loop defined by tasks 210 , 212 , 214 and 216 .
- updated status information from the infusion device 102 may be automatically pushed or uploaded to the support application 118 on the remote device 116 by the client application 108 (e.g., tasks 214 , 220 ), thereby enabling the user at the remote device 116 to monitor the state of the infusion device 102 substantially in real-time as the user interacts with the infusion device 102 and responds to the feedback from the remote device 116 .
- the user of the support application 118 may provide updated feedback or guidance to the client application 108 , which, in turn is presented on the client device 106 (e.g., tasks 220 , 222 ).
- FIGS. 3-8 depict an exemplary sequence of GUI displays that may be presented on an infusion device 302 (e.g., infusion device 102 ) and a paired auxiliary device 306 (e.g., client device 106 ) having a guidance application (e.g., client application 108 ) supporting the interactive guidance process 200 of FIG. 2 executing thereon.
- the infusion device 302 includes a display 326 (e.g., display 1226 ) and user input elements 332 , 334 (e.g., user interface elements 1232 , 1234 ) that allow a user to navigate and interact with the GUI displays presented on the display 326 .
- the client device 306 also similarly includes a display having a guidance GUI display 308 generated by the client application 108 presented thereon.
- FIG. 3 depicts a scenario where the infusion device 302 is presenting the main or primary GUI display 304 for the infusion device 302 (e.g., the “Home Screen”).
- the main GUI display 304 may include standard graphical icons for the current date, time, and other physical device status information (e.g., battery level, network connectivity, fluid remaining in the reservoir, and the like) along with graphical representations of the current state of the physiological condition in the body of the user based on measurement data received from a sensor (e.g., sensing arrangement 104 ).
- a sensor e.g., sensing arrangement 104
- the user of the client device 306 may manipulate the user input elements of the device 306 to initiate, execute, or otherwise open the client application 108 , which, in turn, establishes a communications session with the infusion device 302 and obtains status information describing the current state of the display 326 (e.g., the currently displayed GUI display 304 ), the current state of the user input elements 332 , 334 (including the location of a pointer, mouse, or other user election on or within the currently displayed GUI display 304 ), and the current settings stored or maintained by the infusion device 302 for the various modes or features supported by the infusion device 302 and any customizable or patient-specific parameter values.
- the current state of the display 326 e.g., the currently displayed GUI display 304
- the current state of the user input elements 332 , 334 including the location of a pointer, mouse, or other user election on or within the currently displayed GUI display 304
- the current settings stored or maintained by the infusion device 302 for the various modes or features supported by the infusion device
- the client application 108 may generate an initial GUI display 308 that enables a user to input or otherwise provide indication of his or her objective with respect to the infusion device 302 .
- the initial GUI display 308 may include a list 310 of potential objectives that are selectable by the user.
- the client application 108 accesses the current device settings information obtained from the infusion device 302 (e.g., task 208 ) to verify or otherwise determine whether a bolus wizard feature has been configured or enabled by the user, and in response to determining that the current device setting information indicates the bolus wizard is not configured or enabled, the client application 108 generates a guidance GUI display 408 that enables the user to input or otherwise provide indication of whether he or she would like to configure and enable the bolus wizard or whether he or she would like to bolus manually.
- the client application 108 revises the user objective to enabling the bolus wizard on the infusion device 302 and then generates an updated guidance GUI display 508 including a list or sequence of actions for the user to take using the input elements 332 , 334 of the infusion device 302 to achieve the objective of enabling the bolus wizard feature.
- the updated guidance GUI display 508 includes a list 510 of user actions ordered sequentially for reaching the bolus wizard setup screen(s) from the “Home Screen.”
- the guidance GUI display 508 indicates which user input elements 332 , 334 on the infusion device 302 should be actuated or manipulated by the user, the ordered sequence in which those user input elements 332 , 334 should be actuated, and the number of times a given user input element 332 , 334 should be actuated before moving on to another user input element 332 , 334 or the next action of the sequence.
- a graphical indicia 512 is also presented on the list 510 at the location of the entry for the step in the sequence that the user currently needs to perform.
- entries that have been performed may be graphically deemphasized to reflect their performance and further indicate, to the user, where the user resides within the sequence of actions.
- the first entry in the list 510 for navigating to the “Home Screen” is graphically deemphasized to reflect the current display status of the display 326 and indicate, to the user, where the user resides within the sequence of actions.
- updated user interface status information is automatically pushed from the infusion device 302 to the client application 108 on the client device 306 for dynamically updating the GUI display.
- the infusion device 302 in response to the user actuating the center button on the directional pad 334 when the Home Screen GUI display 304 is presented, the infusion device 302 updates the display 326 to present the Main Menu GUI display 604 and automatically provides updated status information to the client application 108 on the client device 306 that indicates the center button on the directional pad 334 was actuated and that the Main Menu GUI display 604 is currently presented.
- the client application 108 dynamically generates an updated guidance GUI display 608 that reflects the updated user interface status.
- the second entry in the list 510 for navigating to the “Main Menu” is graphically deemphasized to reflect the current display status of the display 326 and the location of the graphical indicia 512 on the list 510 is updated indicate that the user is now on the third entry within the sequence of actions.
- the entry for navigating to the “Main Menu” is updated to reflect a different user action or different user input element 332 , 334 for reverting back to the preceding GUI display.
- the guidance GUI display 608 on the client device 306 corresponds to the state of the GUI display 604 that is concurrently being presented on the display 326 of the infusion device 302 , thereby allowing the user to divert his or her attention seamlessly from the display 326 of the infusion device 302 to the guidance GUI display 608 on the client device 306 and back to the infusion device 302 , while the dynamic updating of the graphical indicia 512 and other guidance information allows the user to keep track of real-time progress on the infusion device 302 when viewing the client device 306 .
- the infusion device 302 in response to the user manipulating the directional pad 334 to navigate through the Main Menu GUI display 604 , the infusion device 302 automatically provides updated user interface status information to the client application 108 that indicates the current user input selection location 704 within the Main Menu GUI display 604 .
- the client application 108 dynamically generates an updated guidance GUI display 708 that reflects a decreased number of user actions with respect to the directional pad 334 for achieving the user's objective from the current user input state 704 .
- the third entry in the list 510 for navigating to the “Options Menu” is updated (relative to guidance GUI display 608 ) to reflect that the user only needs to actuate the down direction of the directional pad 334 three more times instead of the original number of six to reach the “Options Menu” from the current selection location 704 of “Audio Options” within the Main Menu.
- the infusion device 302 automatically provides updated user interface status information to the client application 108 .
- the client application 108 dynamically generates an updated guidance GUI display 808 to reflect a different user action.
- the third entry in the list 510 for navigating to the “Options Menu” is updated (relative to guidance GUI displays 508 , 608 , 708 ) to reflect that the user only needs to actuate the center button of the directional pad 334 to navigate from the Main Menu GUI display 604 to the Options Menu GUI display.
- the third entry in the list 510 for navigating to the “Options Menu” is graphically deemphasized to indicate that the user is now on the fourth entry within the sequence of actions as well as being updated to reflect a different user action or different user input element 332 , 334 for reverting back to the preceding Main Menu GUI display 604 from the Options Menu GUI display in a similar manner as described above.
- the position of the graphical indicia 512 within the list 510 is also updated to horizontally align with the fourth entry in the list 510 .
- the third entry in the list 510 for navigating to the “Options Menu” is updated (relative to guidance GUI displays 508 , 608 , 708 ) to reflect that the user only needs to actuate the up direction of the directional pad 334 to navigate to the Options Menu GUI display. In this manner, the likelihood of the user proceeding to an incorrect GUI display may be reduced.
- FIGS. 9-10 depict another exemplary sequence of GUI displays that may be presented on the client device 306 in concert with the infusion device 302 and the interactive guidance process 200 of FIG. 2 .
- the client application 108 accesses the current device settings information obtained from the infusion device 302 (e.g., task 208 ) to verify or otherwise determine whether a bolus wizard feature has been configured or enabled by the user.
- the client application 108 in response to determining that the current device settings indicate the bolus wizard is configured and enabled, the client application 108 generates a guidance GUI display 908 that enables the user to input or otherwise provide indication of whether he or she would like to utilize the bolus wizard or whether he or she would like to bolus manually.
- the client application 108 in response to selection of a GUI element 912 for using the bolus wizard, the client application 108 generates an updated guidance GUI display 1008 to reflect the user objective of using the bolus wizard.
- the updated guidance GUI display 1008 includes a list 1010 of user actions ordered sequentially for using the bolus wizard.
- FIG. 10 illustrates a list 1010 of user actions ordered sequentially for using the bolus wizard.
- FIG. 10 depicts a scenario after the user has navigated from the Home Screen GUI display 304 to the Main Menu GUI display 604 , with the first entry in the list 1010 for navigating to the “Home Screen” and the second entry in the list 1010 for navigating to the “Main Menu” being graphically deemphasized to reflect the current state of the display 326 in concert with the position of the graphical indicia 512 being updated based on the updated user input selection location 1004 to indicate the user is on the third entry in the list 1010 .
- the list 1010 of actions presented on the guidance GUI display 1008 instructs the user how to further navigate from the Main Menu GUI display to the Bolus Menu GUI display, into the Bolus Wizard GUI display, and from there, what inputs the user should provide and the order in which the user should provide them to achieve delivery of a bolus of fluid using the bolus wizard feature.
- the interactive guidance process 200 may be similarly employed for resolving active alerts, alarms, notifications, or other aspects of the infusion device 102 , 302 .
- the client application 108 may automatically determine the patient's objective is to resolve or understand the current alert or notification and provide a corresponding guidance GUI display that explains the sequence of user actions that may be taken to resolve the alert.
- the guidance GUI display may also include one or more GUI elements that allow the user to change or modify the user objective from what was automatically determined by the client application 108 based on the current display status information.
- the client application 108 may automatically determine the patient's objective is to enable or resume that particular operating mode and provide a corresponding guidance GUI display, which, in turn, may be modified or changed by the user if desired.
- the client application 108 may provide a guidance GUI display that depicts a real-time representation of the GUI display that the pump is currently presenting with callouts, interactive labels, or the like describing what each GUI element on the pump GUI display means or does or other explanatory information regarding the current pump GUI display. Additionally, although not illustrated in FIGS. 3-10 , some embodiments of the client application 108 may include a selectable GUI element outside of the list of user actions that allows the user of the client device 106 , 306 to initiate a remote support session as described above in the context of FIG. 2 .
- FIG. 11 depicts one exemplary embodiment of an infusion system 1100 suitable for use with the patient guidance system 100 of FIG. 1 in conjunction with the interactive guidance process 200 of FIGS. 2-10 .
- the infusion system 1100 includes, without limitation, a fluid infusion device (or infusion pump) 1102 (e.g., infusion device 102 , 302 ), a sensing arrangement 1104 (e.g., sensing arrangement 104 ), a command control device (CCD) 1106 , and a computer 1108 , which could be realized as any one of the computing devices 106 , 114 , 306 described above.
- the CCD 1106 is realized as a client device 106 , 306 and the computer 1108 is realized as remote device 114 .
- an infusion system 1100 may be realized using different platforms, designs, and configurations, and the embodiment shown in FIG. 11 is not exhaustive or limiting.
- the infusion device 1102 and the sensing arrangement 1104 are secured at desired locations on the body of a user (or patient), as illustrated in FIG. 11 .
- the locations at which the infusion device 1102 and the sensing arrangement 1104 are secured to the body of the user in FIG. 11 are provided only as a representative, non-limiting, example.
- the elements of the infusion system 1100 may be similar to those described in U.S. Pat. No. 8,674,288, the subject matter of which is hereby incorporated by reference in its entirety.
- the infusion device 1102 is designed as a portable medical device suitable for infusing a fluid, a liquid, a gel, or other agent into the body of a user.
- the infused fluid is insulin, although many other fluids may be administered through infusion such as, but not limited to, HIV drugs, drugs to treat pulmonary hypertension, iron chelation drugs, pain medications, anti-cancer treatments, medications, vitamins, hormones, or the like.
- the fluid may include a nutritional supplement, a dye, a tracing medium, a saline medium, a hydration medium, or the like.
- the sensing arrangement 1104 generally represents the components of the infusion system 1100 configured to sense, detect, measure or otherwise quantify a condition of the user, and may include a sensor, a monitor, or the like, for providing data indicative of the condition that is sensed, detected, measured or otherwise monitored by the sensing arrangement.
- the sensing arrangement 1104 may include electronics and enzymes reactive to a biological or physiological condition of the user, such as a blood glucose level, or the like, and provide data indicative of the blood glucose level to the infusion device 1102 , the CCD 1106 and/or the computer 1108 .
- the infusion device 1102 , the CCD 1106 and/or the computer 1108 may include a display for presenting information or data to the user based on the sensor data received from the sensing arrangement 1104 , such as, for example, a current glucose level of the user, a graph or chart of the user's glucose level versus time, device status indicators, alert messages, or the like.
- the infusion device 1102 , the CCD 1106 and/or the computer 1108 may include electronics and software that are configured to analyze sensor data and operate the infusion device 1102 to deliver fluid to the body of the user based on the sensor data and/or preprogrammed delivery routines.
- one or more of the infusion device 1102 , the sensing arrangement 1104 , the CCD 1106 , and/or the computer 1108 includes a transmitter, a receiver, and/or other transceiver electronics that allow for communication with other components of the infusion system 1100 , so that the sensing arrangement 1104 may transmit sensor data or monitor data to one or more of the infusion device 1102 , the CCD 1106 and/or the computer 1108 .
- the sensing arrangement 1104 may be secured to the body of the user or embedded in the body of the user at a location that is remote from the location at which the infusion device 1102 is secured to the body of the user. In various other embodiments, the sensing arrangement 1104 may be incorporated within the infusion device 1102 . In other embodiments, the sensing arrangement 1104 may be separate and apart from the infusion device 1102 , and may be, for example, part of the CCD 1106 . In such embodiments, the sensing arrangement 1104 may be configured to receive a biological sample, analyte, or the like, to measure a condition of the user.
- the CCD 1106 and/or the computer 1108 may include electronics and other components configured to perform processing, delivery routine storage, and to control the infusion device 1102 in a manner that is influenced by sensor data measured by and/or received from the sensing arrangement 1104 .
- the infusion device 1102 may be made with more simplified electronics.
- the infusion device 1102 may include all control functions, and may operate without the CCD 1106 and/or the computer 1108 .
- the CCD 1106 may be a portable electronic device.
- the infusion device 1102 and/or the sensing arrangement 1104 may be configured to transmit data to the CCD 1106 and/or the computer 1108 for display or processing of the data by the CCD 1106 and/or the computer 1108 .
- the CCD 1106 and/or the computer 1108 may provide information to the user that facilitates the user's subsequent use of the infusion device 1102 .
- the CCD 1106 may provide information to the user to allow the user to determine the rate or dose of medication to be administered into the user's body.
- the CCD 1106 may provide information to the infusion device 1102 to autonomously control the rate or dose of medication administered into the body of the user.
- the sensing arrangement 1104 may be integrated into the CCD 1106 . Such embodiments may allow the user to monitor a condition by providing, for example, a sample of his or her blood to the sensing arrangement 1104 to assess his or her condition.
- the sensing arrangement 1104 and the CCD 1106 may be used for determining glucose levels in the blood and/or body fluids of the user without the use of, or necessity of, a wire or cable connection between the infusion device 1102 and the sensing arrangement 1104 and/or the CCD 1106 .
- the sensing arrangement 1104 and/or the infusion device 1102 are cooperatively configured to utilize a closed-loop system for delivering fluid to the user.
- a closed-loop system for delivering fluid to the user.
- Examples of sensing devices and/or infusion pumps utilizing closed-loop systems may be found at, but are not limited to, the following U.S. Pat. Nos. 6,088,608, 6,119,028, 6,589,229, 6,740,072, 6,827,702, 7,323,142, and 7,402,153, all of which are incorporated herein by reference in their entirety.
- the sensing arrangement 1104 is configured to sense or measure a condition of the user, such as, blood glucose level or the like.
- the infusion device 1102 is configured to deliver fluid in response to the condition sensed by the sensing arrangement 1104 .
- the sensing arrangement 1104 continues to sense or otherwise quantify a current condition of the user, thereby allowing the infusion device 1102 to deliver fluid continuously in response to the condition currently (or most recently) sensed by the sensing arrangement 1104 indefinitely.
- the sensing arrangement 1104 and/or the infusion device 1102 may be configured to utilize the closed-loop system only for a portion of the day, for example only when the user is asleep or awake.
- FIGS. 12-14 depict one exemplary embodiment of a fluid infusion device 1200 (or alternatively, infusion pump) suitable for use as an infusion device 102 , 302 , 1102 described above in the context of FIGS. 1-11 .
- the fluid infusion device 1200 is a portable medical device designed to be carried or worn by a patient (or user), and the fluid infusion device 1200 may leverage any number of conventional features, components, elements, and characteristics of existing fluid infusion devices, such as, for example, some of the features, components, elements, and/or characteristics described in U.S. Pat. Nos. 6,485,465 and 7,621,893. It should be appreciated that FIGS. 12-14 depict some aspects of the infusion device 1200 in a simplified manner; in practice, the infusion device 1200 could include additional elements, features, or components that are not shown or described in detail herein.
- the illustrated embodiment of the fluid infusion device 1200 includes a housing 1202 adapted to receive a fluid-containing reservoir 1205 .
- An opening 1220 in the housing 1202 accommodates a fitting 1223 (or cap) for the reservoir 1205 , with the fitting 1223 being configured to mate or otherwise interface with tubing 1221 of an infusion set 1225 that provides a fluid path to/from the body of the user. In this manner, fluid communication from the interior of the reservoir 1205 to the user is established via the tubing 1221 .
- the illustrated fluid infusion device 1200 includes a human-machine interface (HMI) 1230 (or user interface) that includes elements 1232 , 1234 that can be manipulated by the user to administer a bolus of fluid (e.g., insulin), to change therapy settings, to change user preferences, to select display features, and the like.
- HMI human-machine interface
- the infusion device also includes a display element 1226 , such as a liquid crystal display (LCD) or another suitable display element, that can be used to present various types of information or data to the user, such as, without limitation: the current glucose level of the patient; the time; a graph or chart of the patient's glucose level versus time; device status indicators; etc.
- LCD liquid crystal display
- the housing 1202 is formed from a substantially rigid material having a hollow interior 1014 adapted to allow an electronics assembly 1204 , a sliding member (or slide) 1206 , a drive system 1208 , a sensor assembly 1210 , and a drive system capping member 1212 to be disposed therein in addition to the reservoir 1205 , with the contents of the housing 1202 being enclosed by a housing capping member 1216 .
- the opening 1220 , the slide 1206 , and the drive system 1208 are coaxially aligned in an axial direction (indicated by arrow 1218 ), whereby the drive system 1208 facilitates linear displacement of the slide 1206 in the axial direction 1218 to dispense fluid from the reservoir 1205 (after the reservoir 1205 has been inserted into opening 1220 ), with the sensor assembly 1210 being configured to measure axial forces (e.g., forces aligned with the axial direction 1218 ) exerted on the sensor assembly 1210 responsive to operating the drive system 1208 to displace the slide 1206 .
- axial forces e.g., forces aligned with the axial direction 1218
- the sensor assembly 1210 may be utilized to detect one or more of the following: an occlusion in a fluid path that slows, prevents, or otherwise degrades fluid delivery from the reservoir 1205 to a user's body; when the reservoir 1205 is empty; when the slide 1206 is properly seated with the reservoir 1205 ; when a fluid dose has been delivered; when the infusion pump 1200 is subjected to shock or vibration; when the infusion pump 1200 requires maintenance.
- the fluid-containing reservoir 1205 may be realized as a syringe, a vial, a cartridge, a bag, or the like.
- the infused fluid is insulin, although many other fluids may be administered through infusion such as, but not limited to, HIV drugs, drugs to treat pulmonary hypertension, iron chelation drugs, pain medications, anti-cancer treatments, medications, vitamins, hormones, or the like.
- the reservoir 1205 typically includes a reservoir barrel 1219 that contains the fluid and is concentrically and/or coaxially aligned with the slide 1206 (e.g., in the axial direction 1218 ) when the reservoir 1205 is inserted into the infusion pump 1200 .
- the end of the reservoir 1205 proximate the opening 1220 may include or otherwise mate with the fitting 1223 , which secures the reservoir 1205 in the housing 1202 and prevents displacement of the reservoir 1205 in the axial direction 1218 with respect to the housing 1202 after the reservoir 1205 is inserted into the housing 1202 .
- the fitting 1223 extends from (or through) the opening 1220 of the housing 1202 and mates with tubing 1221 to establish fluid communication from the interior of the reservoir 1205 (e.g., reservoir barrel 1219 ) to the user via the tubing 1221 and infusion set 1225 .
- the opposing end of the reservoir 1205 proximate the slide 1206 includes a plunger 1217 (or stopper) positioned to push fluid from inside the barrel 1219 of the reservoir 1205 along a fluid path through tubing 1221 to a user.
- the slide 1206 is configured to mechanically couple or otherwise engage with the plunger 1217 , thereby becoming seated with the plunger 1217 and/or reservoir 1205 .
- Fluid is forced from the reservoir 1205 via tubing 1221 as the drive system 1208 is operated to displace the slide 1206 in the axial direction 1218 toward the opening 1220 in the housing 1202 .
- the drive system 1208 includes a motor assembly 1207 and a drive screw 1209 .
- the motor assembly 1207 includes a motor that is coupled to drive train components of the drive system 1208 that are configured to convert rotational motor motion to a translational displacement of the slide 1206 in the axial direction 1218 , and thereby engaging and displacing the plunger 1217 of the reservoir 1205 in the axial direction 1218 .
- the motor assembly 1207 may also be powered to translate the slide 1206 in the opposing direction (e.g., the direction opposite direction 1218 ) to retract and/or detach from the reservoir 1205 to allow the reservoir 1205 to be replaced.
- the motor assembly 1207 includes a brushless DC (BLDC) motor having one or more permanent magnets mounted, affixed, or otherwise disposed on its rotor.
- BLDC brushless DC
- the motor may be realized as a solenoid motor, an AC motor, a stepper motor, a piezoelectric caterpillar drive, a shape memory actuator drive, an electrochemical gas cell, a thermally driven gas cell, a bimetallic actuator, or the like.
- the drive train components may comprise one or more lead screws, cams, ratchets, jacks, pulleys, pawls, clamps, gears, nuts, slides, bearings, levers, beams, stoppers, plungers, sliders, brackets, guides, bearings, supports, bellows, caps, diaphragms, bags, heaters, or the like.
- the illustrated embodiment of the infusion pump utilizes a coaxially aligned drive train
- the motor could be arranged in an offset or otherwise non-coaxial manner, relative to the longitudinal axis of the reservoir 1205 .
- the drive screw 1209 mates with threads 1402 internal to the slide 1206 .
- the motor assembly 1207 is powered and operated, the drive screw 1209 rotates, and the slide 1206 is forced to translate in the axial direction 1218 .
- the infusion pump 1200 includes a sleeve 1211 to prevent the slide 1206 from rotating when the drive screw 1209 of the drive system 1208 rotates.
- rotation of the drive screw 1209 causes the slide 1206 to extend or retract relative to the drive motor assembly 1207 .
- the slide 1206 contacts the plunger 1217 to engage the reservoir 1205 and control delivery of fluid from the infusion pump 1200 .
- the shoulder portion 1215 of the slide 1206 contacts or otherwise engages the plunger 1217 to displace the plunger 1217 in the axial direction 1218 .
- the slide 1206 may include a threaded tip 1213 capable of being detachably engaged with internal threads 1404 on the plunger 1217 of the reservoir 1205 , as described in detail in U.S. Pat. Nos. 6,248,093 and 6,485,465, which are incorporated by reference herein.
- the electronics assembly 1204 includes control electronics 1224 coupled to the display element 1226 , with the housing 1202 including a transparent window portion 1228 that is aligned with the display element 1226 to allow the display 1226 to be viewed by the user when the electronics assembly 1204 is disposed within the interior 1014 of the housing 1202 .
- the control electronics 1224 generally represent the hardware, firmware, processing logic and/or software (or combinations thereof) configured to control operation of the motor assembly 1207 and/or drive system 1208 . Whether such functionality is implemented as hardware, firmware, a state machine, or software depends upon the particular application and design constraints imposed on the embodiment.
- control electronics 1224 includes one or more programmable controllers that may be programmed to control operation of the infusion pump 1200 .
- the motor assembly 1207 includes one or more electrical leads 1236 adapted to be electrically coupled to the electronics assembly 1204 to establish communication between the control electronics 1224 and the motor assembly 1207 .
- a motor driver e.g., a power converter
- the motor actuates the drive train components of the drive system 1208 to displace the slide 1206 in the axial direction 1218 to force fluid from the reservoir 1205 along a fluid path (including tubing 1221 and an infusion set), thereby administering doses of the fluid contained in the reservoir 1205 into the user's body.
- the power supply is realized one or more batteries contained within the housing 1202 .
- the power supply may be a solar panel, capacitor, AC or DC power supplied through a power cord, or the like.
- the control electronics 1224 may operate the motor of the motor assembly 1207 and/or drive system 1208 in a stepwise manner, typically on an intermittent basis; to administer discrete precise doses of the fluid to the user according to programmed delivery profiles.
- the user interface 1230 includes HMI elements, such as buttons 1232 and a directional pad 1234 , that are formed on a graphic keypad overlay 1231 that overlies a keypad assembly 1233 , which includes features corresponding to the buttons 1232 , directional pad 1234 or other user interface items indicated by the graphic keypad overlay 1231 .
- HMI elements such as buttons 1232 and a directional pad 1234 , that are formed on a graphic keypad overlay 1231 that overlies a keypad assembly 1233 , which includes features corresponding to the buttons 1232 , directional pad 1234 or other user interface items indicated by the graphic keypad overlay 1231 .
- the keypad assembly 1233 When assembled, the keypad assembly 1233 is coupled to the control electronics 1224 , thereby allowing the HMI elements 1232 , 1234 to be manipulated by the user to interact with the control electronics 1224 and control operation of the infusion pump 1200 , for example, to administer a bolus of insulin, to change therapy settings, to change user preferences, to select display features, to set or disable alarms and reminders, and the like.
- the control electronics 1224 maintains and/or provides information to the display 1226 regarding program parameters, delivery profiles, pump operation, alarms, warnings, statuses, or the like, which may be adjusted using the HMI elements 1232 , 1234 .
- the HMI elements 1232 , 1234 may be realized as physical objects (e.g., buttons, knobs, joysticks, and the like) or virtual objects (e.g., using touch-sensing and/or proximity-sensing technologies).
- the display 1226 may be realized as a touch screen or touch-sensitive display, and in such embodiments, the features and/or functionality of the HMI elements 1232 , 1234 may be integrated into the display 1226 and the HMI 1230 may not be present.
- the electronics assembly 1204 may also include alert generating elements coupled to the control electronics 1224 and suitably configured to generate one or more types of feedback, such as, without limitation: audible feedback; visual feedback; haptic (physical) feedback; or the like.
- the sensor assembly 1210 includes a back plate structure 1250 and a loading element 1260 .
- the loading element 1260 is disposed between the capping member 1212 and a beam structure 1270 that includes one or more beams having sensing elements disposed thereon that are influenced by compressive force applied to the sensor assembly 1210 that deflects the one or more beams, as described in greater detail in U.S. Pat. No. 8,474,332, which is incorporated by reference herein.
- the back plate structure 1250 is affixed, adhered, mounted, or otherwise mechanically coupled to the bottom surface 1238 of the drive system 1208 such that the back plate structure 1250 resides between the bottom surface 1238 of the drive system 1208 and the housing cap 1216 .
- the drive system capping member 1212 is contoured to accommodate and conform to the bottom of the sensor assembly 1210 and the drive system 1208 .
- the drive system capping member 1212 may be affixed to the interior of the housing 1202 to prevent displacement of the sensor assembly 1210 in the direction opposite the direction of force provided by the drive system 1208 (e.g., the direction opposite direction 1218 ).
- the sensor assembly 1210 is positioned between the motor assembly 1207 and secured by the capping member 1212 , which prevents displacement of the sensor assembly 1210 in a downward direction opposite the direction of arrow 1218 , such that the sensor assembly 1210 is subjected to a reactionary compressive force when the drive system 1208 and/or motor assembly 1207 is operated to displace the slide 1206 in the axial direction 1218 in opposition to the fluid pressure in the reservoir 1205 .
- the compressive force applied to the sensor assembly 1210 is correlated with the fluid pressure in the reservoir 1205 .
- electrical leads 1240 are adapted to electrically couple the sensing elements of the sensor assembly 1210 to the electronics assembly 1204 to establish communication to the control electronics 1224 , wherein the control electronics 1224 are configured to measure, receive, or otherwise obtain electrical signals from the sensing elements of the sensor assembly 1210 that are indicative of the force applied by the drive system 1208 in the axial direction 1218 .
- FIG. 15 depicts an exemplary embodiment of a medical device 1500 suitable for use as the infusion device 102 , 302 , 1102 , 1200 in conjunction with the interactive guidance process 200 of FIGS. 2-10 .
- the illustrated medical device 1500 includes, without limitation, a control module 1502 , a communications interface 1504 , a display device 1506 , a user interface 1508 , and a data storage element (or memory) 1510 .
- the control module 1502 is coupled to the communications interface 1504 , the memory 1510 , the display device 1506 , and the memory 1006 , and the control module 1502 is suitably configured to support the operations, tasks, and/or processes described herein.
- FIG. 15 is a simplified representation of a medical device 1500 for purposes of explanation and is not intended to limit the subject matter described herein in any way.
- the communications interface 1504 generally represents the hardware, circuitry, logic, firmware and/or other components of the medical device 1500 that are coupled to the control module 1502 and configured to support communications sessions between the medical device 1500 and an auxiliary device (e.g., devices 106 , 306 , 1106 ) via a network (e.g., network 110 ).
- the communications interface 1504 may include or otherwise be coupled to one or more transceiver modules capable of supporting wireless communications.
- the communications interface 1504 may be configured to support wired communications to/from the auxiliary device.
- the display device 1506 may be realized as any sort of electronic display capable of graphically displaying information or other data associated with operation of the medical device 1500 under control of the control module 1502 .
- the user interface 1508 generally includes one or more user input devices configured to allow a patient or other user to interact with the medical device 1500 and the GUI displays presented on the display device 1506 .
- the user interface 1508 may include or be realized as one or more of the following user input devices: a keypad, touchpad, keyboard, mouse, touch panel (or touchscreen), joystick, knob, line select key or another suitable device adapted to receive input from a user, such as a microphone, audio transducer, audio sensor, or another audio input device.
- the control module 1502 generally represents the hardware, circuitry, logic, firmware and/or other component of the medical device 1500 configured to determine dosage commands for operating medical device 1500 (e.g., by operating an actuation arrangement to deliver fluid to the body of a patient) and perform various additional tasks, operations, functions and/or operations described herein.
- control module 1502 implements or otherwise executes an application that supports establishing communications sessions with a guidance application on an auxiliary device and automatically pushing or uploading status information, settings information, and the like to the guidance application asynchronously or in another substantially real-time manner.
- control module 1502 may be implemented or realized with a general purpose processor, a microprocessor, a controller, a microcontroller, a state machine, a content addressable memory, an application specific integrated circuit, a field programmable gate array, any suitable programmable logic device, discrete gate or transistor logic, discrete hardware components, or any combination thereof, designed to perform the functions described herein.
- steps of a method or algorithm described in connection with the embodiments disclosed herein may be embodied directly in hardware, in firmware, in a software module executed by the control module 1502 , or in any practical combination thereof.
- control module 1502 includes or otherwise accesses the data storage element or memory 1510 , which may be realized using any sort of non-transitory computer-readable medium capable of storing programming instructions for execution by the control module 1502 .
- the computer-executable programming instructions when read and executed by the control module 1502 , cause the control module 1502 to implement or otherwise generate the guidance communications application and perform tasks, operations, functions, and processes described herein.
- the memory 1510 may also store or otherwise maintain settings information for the medical device 1500 including, but not limited to, data indicating which modes or features of the medical device 1500 have been configured, data indicating which modes or features of the medical device 1500 have not been configured, data indicating which modes or features of the medical device 1500 are enabled or activated, data indicating which modes or features of the medical device 1500 have been disabled or deactivated, variables, parameters, or other values that have been programmed, configured, entered, or otherwise established for use by a particular mode or feature of the medical device 1500 , and any patient-specific variables, parameters, or other values that have been programmed, configured, entered or otherwise established for use by a particular mode or feature of the medical device 1500 .
- the settings information may include configuration data for an operating mode of the medical device 1500 , configuration data for a feature of the medical device 1500 , or values or data for other patient-specific settings, parameters, or variables.
- the settings information could include a value for a basal rate, a patient-specific insulin sensitivity factor, a patient-specific insulin-to-carbohydrate ratio, a patient-specific total daily insulin requirement, or the like.
- the control module 1502 in response to establishing a communications session with an auxiliary device via the communications interface 1504 , is configured to identify or otherwise obtain status information characterizing the current state of the display device 1506 and the user interface 1508 and the settings information stored by the memory 1510 and transmit the settings information and the status information to the auxiliary device via the communications session.
- the control module 1502 automatically identifies or obtains updated status information characterizing the updated state of the display device 1506 and the user interface 1508 responsive to the user input and automatically pushes, uploads, or otherwise transmits the updated status information to the auxiliary device, which, in turn, allows the auxiliary device to dynamically update any guidance information presented to a user at the auxiliary device.
- the guidance information may include a sequence of one or more user actions with respect to the user interface 1508 for operating the medical device 1500 to deliver a bolus of fluid, configuring or enabling an operating mode or feature of the medical device 1500 (e.g., a closed-loop operating mode, a bolus wizard feature, or the like), programming patient-specific variables, parameters, or other settings into the medical device 1500 , and/or the like, with the sequence of user actions being dynamically updated to reflect or distinguish those user actions that have already been performed.
- an operating mode or feature of the medical device 1500 e.g., a closed-loop operating mode, a bolus wizard feature, or the like
- programming patient-specific variables, parameters, or other settings into the medical device 1500 e.g., a closed-loop operating mode, a bolus wizard feature, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Anesthesiology (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
- Embodiments of the subject matter described herein relate generally to medical devices, and more particularly, embodiments of the subject matter relate to facilitating patient operation of a medical device.
- Infusion pump devices and systems are relatively well known in the medical arts, for use in delivering or dispensing an agent, such as insulin or another prescribed medication, to a patient. A typical infusion pump includes a pump drive system which typically includes a small motor and drive train components that convert rotational motor motion to a translational displacement of a plunger (or stopper) in a reservoir that delivers medication from the reservoir to the body of a user via a fluid path created between the reservoir and the body of a user. Use of infusion pump therapy has been increasing, especially for delivering insulin for diabetics.
- Control schemes have been developed that allow insulin infusion pumps to monitor and regulate a user's blood glucose level in a substantially continuous and autonomous manner. However, regulating blood glucose level is still complicated by variations in a user's individual insulin response and daily activities (e.g., exercise, carbohydrate consumption, bolus administration, and the like) in conjunction with variations associated with the devices or components used to implement continuous glucose monitoring and related controls, and potentially other factors that may contribute to variations, uncertainty, or otherwise impair accuracy or reliability. Since many of the variables influencing glucose regulation and control may often be dynamically or periodically changing, some user involvement with the infusion pump may be desirable to achieve the desired performance and outcomes.
- Modern devices may incorporate or support any number of potential features as well as utilizing various user interface(s), which may be unique to a particular device. Therefore, it is desirable for device manufacturers to provide additional consumer education. Traditionally, product manuals or guides documenting the various aspects of the device were provided. For some users, printed documentation can be disfavored and neglected. At the same time, due to regulatory requirements or other concerns, medical devices may not be as equipped as other computer devices for providing consumer education features electronically. Though customer service or other manufacturer support may be available by phone or email, many users tend to find invoking such services to be time consuming and inconvenient. Accordingly, there is a need to provide consumer education in a manner that is simple, convenient, and efficient to enable maximizing device performance for optimal patient outcomes.
- Medical devices and related systems and operating methods are provided. An exemplary method of interactively providing guidance facilitating operation of a medical device involves identifying, at a computing device communicatively coupled to the medical device, a user objective associated with the medical device, obtaining, at the computing device from the medical device, user interface status information corresponding to a current state of a user interface of the medical device, and providing, on a display associated with the computing device, guidance information influenced by the user interface status information and the user objective. Subsequently, updated user interface status information for the infusion device responsive to a user input with respect to the infusion device may be provided to the computing device, with the guidance information being dynamically updated in response to the updated status information.
- In another embodiment, an apparatus for a medical device is provided. The medical device includes a display to provide one or more graphical user interface displays, a user interface element to receive a user input, a data storage element to maintain settings information, a communications interface communicatively coupled to a network, and control module coupled to the display, the user interface element, the data storage element, and the communications interface. The control module is configurable to transmit the settings information and status information characterizing a state of the display to an auxiliary device via the network, and in response to the user input, automatically push updated status information characterizing an updated state of the display responsive to the user input to the auxiliary device via the network.
- Another embodiment of a method of facilitating operation of an infusion device to deliver a fluid influencing a physiological condition to a body of a user involves identifying, at a computing device communicatively coupled to the infusion device, an objective associated with the infusion device. obtaining, at the computing device from the infusion device via a network, current user interface status information for the infusion device, and generating, at the computing device, a guidance graphical user interface display comprising a sequence of one or more user actions with respect to the infusion device for achieving the objective based at least in part on the current user interface status information.
- This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the detailed description. This summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject matter.
- A more complete understanding of the subject matter may be derived by referring to the detailed description and claims when considered in conjunction with the following figures, wherein like reference numbers refer to similar elements throughout the figures, which may be illustrated for simplicity and clarity and are not necessarily drawn to scale.
-
FIG. 1 depicts an exemplary embodiment of a patient guidance system; -
FIG. 2 is a flow diagram of an exemplary interactive guidance process suitable for use with the patient guidance system ofFIG. 1 in one or more exemplary embodiments; -
FIGS. 3-8 depict a sequence of graphical user interface displays that may be presented in conjunction with the interactive guidance process ofFIG. 2 in one embodiment; -
FIGS. 9-10 depict another sequence of graphical user interface displays that may be presented in conjunction with the interactive guidance process ofFIG. 2 in another embodiment; -
FIG. 11 depicts an exemplary embodiment of an infusion system; -
FIG. 12 depicts a plan view of an exemplary embodiment of a fluid infusion device suitable for use in the infusion system ofFIG. 11 ; -
FIG. 13 is an exploded perspective view of the fluid infusion device ofFIG. 12 ; -
FIG. 14 is a cross-sectional view of the fluid infusion device ofFIGS. 12-13 as viewed along line 14-14 inFIG. 13 when assembled with a reservoir inserted in the infusion device; and -
FIG. 15 is a block diagram of an exemplary medical device suitable for use in conjunction with the interactive guidance process ofFIG. 2 in accordance with one or more exemplary embodiments. - The following detailed description is merely illustrative in nature and is not intended to limit the embodiments of the subject matter or the application and uses of such embodiments. As used herein, the word “exemplary” means “serving as an example, instance, or illustration.” Any implementation described herein as exemplary is not necessarily to be construed as preferred or advantageous over other implementations. Furthermore, there is no intention to be bound by any expressed or implied theory presented in the preceding technical field, background, brief summary or the following detailed description.
- Exemplary embodiments of the subject matter described herein are implemented in conjunction with medical devices, such as portable electronic medical devices. Although many different applications are possible, the following description focuses on embodiments that incorporate a fluid infusion device (or infusion pump) as part of an infusion system deployment. For the sake of brevity, conventional techniques related to infusion system operation, insulin pump and/or infusion set operation, and other functional aspects of the systems (and the individual operating components of the systems) may not be described in detail here. Examples of infusion pumps may be of the type described in, but not limited to, U.S. Pat. Nos. 4,562,751; 4,685,903; 5,080,653; 5,505,709; 5,097,122; 6,485,465; 6,554,798; 6,558,320; 6,558,351; 6,641,533; 6,659,980; 6,752,787; 6,817,990; 6,932,584; and 7,621,893; each of which are herein incorporated by reference. That said, the subject matter described herein can be utilized more generally in the context of overall diabetes management or other physiological conditions, and the subject matter described herein is not limited to any particular type of medication or medical device being utilized.
- Generally, a fluid infusion device includes a motor or other actuation arrangement that is operable to linearly displace a plunger (or stopper) of a reservoir provided within the fluid infusion device to deliver a dosage of fluid, such as insulin, to the body of a user. Dosage commands that govern operation of the motor may be generated in an automated manner in accordance with the delivery control scheme associated with a particular operating mode, and the dosage commands may be generated in a manner that is influenced by a current (or most recent) measurement of a physiological condition in the body of the user. For example, in a closed-loop operating mode, dosage commands may be generated based on a difference between a current (or most recent) measurement of the interstitial fluid glucose level in the body of the user and a target (or reference) glucose value. In this regard, the rate of infusion may vary as the difference between a current measurement value and the target measurement value fluctuates. For purposes of explanation, the subject matter is described herein in the context of the infused fluid being insulin for regulating a glucose level of a user (or patient); however, it should be appreciated that many other fluids may be administered through infusion, and the subject matter described herein is not necessarily limited to use with insulin.
- Exemplary embodiments described herein generally relate to systems and methods of interactively providing guidance information pertaining to a medical device for review or action by a user on an auxiliary device, such as a computer, a smartphone, or the like, to help facilitate the configuration or operation of various features of a medical device. As described in greater detail below, the auxiliary device identifies or otherwise determines the user's objective associated with the medical device, such as, for example, what the user wants to accomplish using the medical device, what aspect of the medical device the user has questions about, or the like. The auxiliary device also obtains, from the medical device, status information that characterizes, describes, or otherwise corresponds to a current state of a user interface of the medical device. In this regard, the user interface status information may indicate a current graphical user interface (GUI) displayed on a display of the medical device and a current selection or position of a user input element on the display. Based on the current user interface status information and the user's objective, the guidance information indicative of the user actions for accomplishing the user's objective is determined and presented or otherwise provided on a display associated with the auxiliary device for review by the user. In this regard, the user may concurrently view the guidance information for accomplishing the objective presented on the auxiliary device while interacting with the medical device in accordance with the guidance information.
- In exemplary embodiments, the auxiliary device and the medical device are paired over a communications network, so that the medical device may upload, push, or otherwise transmit updated user interface status information to the auxiliary device substantially in real-time in response to a user input or other interaction with the medical device. In response to obtaining indication of the updated state of the user interface of the medical device, the guidance information presented on the auxiliary device is dynamically updated to reflect how the user input influenced the user actions for accomplishing the user's objective from the updated user interface state. Thus, as the user navigates through various menus or GUI display screens on the medical device, the guidance information on the auxiliary device may be dynamically updated substantially concurrently, allowing the user to move back and forth across displays seamlessly.
- In one or more embodiments, the auxiliary device also obtains operational settings or other device configuration information from the medical device to provide guidance information consistent with the current device setup or other user- or patient-specific configurations. For example, if the user's objective is to administer a bolus using the infusion device, the operational settings information obtained by the auxiliary device may indicate that a bolus wizard feature of the infusion device has not been setup, in which case the guidance information may provide instructions for how to configure or setup the bolus wizard. Conversely, when the operational settings information indicates the bolus wizard feature has been setup and is currently enabled, the guidance information may provide instructions for utilizing the bolus wizard. In this regard, for device features or modes that require specific user inputs, patient-specific parameters, or other actions before they are enabled or operable, the guidance information may instruct the user for configuring and enabling such features. At the same time, by virtue of obtaining the settings information, the provided guidance information does not pertain to device features or operating modes that the user has not enabled, configured, or otherwise activated. Thus, the user may be provided only with guidance information pertinent to both the current device configuration and the user's objective. As such, providing potentially non-pertinent or non-actionable information is avoided, which improves the user experience.
-
FIG. 1 depicts an exemplary embodiment of apatient guidance system 100. Thepatient guidance system 100 includes aninfusion device 102 communicatively coupled to anauxiliary device 106 via anetwork 110. As described in greater detail below in the context ofFIGS. 2-10 , theauxiliary device 106 supports anapplication 108 that generates and provides guidance information on a display associated with theauxiliary device 108 that includes instructions or other indication of user actions for accomplishing an objective associated with theinfusion device 102 based on that objective and the current user interface status for theinfusion device 102 received via thenetwork 110. In the illustrated embodiment, theinfusion device 102 is also communicatively coupled to asensing arrangement 104 to obtain measurement data indicative of a physiological condition in the body of a patient, such as sensor glucose measurement values. For example, in one or more exemplary embodiments, theinfusion device 102 operates autonomously to regulate the patient's glucose level based on the sensor glucose measurement values received from thesensing arrangement 104. - The
auxiliary device 106 represents an electronic device capable of communicating with theinfusion device 102 viacommunications network 110. In exemplary embodiments, thenetwork 110 is realized as a Bluetooth network, a ZigBee network, a wireless local area network (WLAN), or another suitable personal area network or local area network (LAN). That said, in other embodiments, theinfusion device 102 and theauxiliary device 106 may communicate via a direct communications interface, such as a wire, cable, infrared, or some other short range communications medium. Depending on the embodiment, theauxiliary device 106 may be realized as any sort of electronic device capable of communicating with theinfusion device 102 vianetwork 110, such as a mobile telephone, a smartphone, a laptop or notebook computer, a tablet computer, a desktop computer, a personal digital assistant, or the like. For purposes of explanation, but without limitation, theauxiliary device 106 may alternatively be referred to herein as a client device. Theclient device 106 includes or is coupled to a display device, such as a monitor, screen, or another conventional electronic display, capable of graphically presenting data and/or information. Theclient device 106 also includes or is otherwise associated with a user input device, such as a keyboard, a mouse, a touchscreen, or the like, capable of receiving input data and/or other information from the user of theclient device 106. - In one or more embodiments, a user, such as the patient, the patient's doctor or another healthcare provider, or the like, manipulates the
client device 106 to execute aclient application 108 that communicates with theinfusion device 102 via thenetwork 110 using a networking protocol. Theclient application 108 supports establishing a communications session with theinfusion device 102 on thenetwork 110 and receiving data and/or information from theinfusion device 102 via the communications session. In this regard, theinfusion device 102 may execute or otherwise implement a corresponding application or process that supports establishing the communications session with theclient application 108. Theclient application 108 generally represents a software module or another feature that is generated or otherwise implemented by theclient device 106 to support the processes described herein. In such embodiments, theclient device 106 includes a processing system and a data storage element (or memory) capable of storing programming instructions for execution by the processing system, that, when read and executed, cause processing system to create, generate, or otherwise facilitate theclient application 108 and perform or otherwise support the processes, tasks, operations, and/or functions described herein. Depending on the embodiment, the processing system may be implemented using any suitable processing system and/or device, such as, for example, one or more processors, central processing units (CPUs), controllers, microprocessors, microcontrollers, processing cores and/or other hardware computing resources configured to support the operation of the processing system described herein. Similarly, the data storage element or memory may be realized as a random access memory (RAM), read only memory (ROM), flash memory, magnetic or optical mass storage, or any other suitable non-transitory short or long term data storage or other computer-readable media, and/or any suitable combination thereof. - In one or more embodiments, the
infusion device 102 and theclient device 106 establish an association (or pairing) with one another over thenetwork 110 to support subsequently establishing a peer-to-peer communication session between theinfusion device 102 and theclient device 106 via thenetwork 110. For example, in accordance with one embodiment, thenetwork 110 is realized as a Bluetooth network, wherein theinfusion device 102 and theclient device 106 are paired with one another (e.g., by obtaining and storing network identification information for one another) by performing a discovery procedure or another suitable pairing procedure. In this regard, the pairing information obtained during the discovery procedure allows either of theinfusion device 102 or theclient device 106 to initiate the establishment of a secure peer-to-peer communication session via thenetwork 110. Some examples of an infusion device pairing with a client device are described in United States Patent Application Publication Nos. 2015/0057807 and 2015/0057634, which are incorporated by reference herein in their entirety. - In one or more exemplary embodiments, the
client application 108 is configured to store or otherwise maintain an address and/or other identification information for aremote device 114 on anothernetwork 112. In this regard, thesecond network 112 may be physically and/or logically distinct from thenetwork 110, such as, for example, the Internet, a cellular network, a wide area network (WAN), or the like. Theremote device 114 generally represents a computing device that includes or otherwise implements asupport application 116 configured to receive or otherwise obtain the current user interface status information for theinfusion device 102 and the current user objective from theclient application 108 and present the information to another user operating theremote device 114 for analysis. For example, theremote device 114 may be utilized by customer service personnel to provide customer support in the event the patient or user of theclient device 108 is having difficulty accomplishing his or her objective with respect to theinfusion device 102, as described in greater detail below in the context ofFIG. 2 . Theremote device 114 may reside at a location that is physically distinct and/or separate from theinfusion device 102, such as, for example, at a facility that is owned and/or operated by or otherwise affiliated with a manufacturer of theinfusion device 102. - It should be appreciated that
FIG. 1 depicts a simplified representation of apatient guidance system 100 for purposes of explanation and is not intended to limit the subject matter described herein in any way. For example, in various embodiments, one or more of thedevices patient guidance system 100. Additionally, whileFIG. 1 depicts asingle sensing arrangement 104, in practice, embodiments of thepatient guidance system 100 may include multiple different sensing arrangements, which may be configured to sense, measure, or otherwise quantify any number of conditions or characteristics. For example, multiple instances of aglucose sensing arrangement 104 may be deployed for redundancy or other purposes (e.g., averaging or other statistical operations). In other embodiments,additional sensing arrangements 104 may be deployed to measure different physiological conditions of the patient, such as, for example, the patient's heart rate, oxygen levels, or the like. -
FIG. 2 depicts an exemplaryinteractive guidance process 200 suitable for implementation by a patient guidance system to provide guidance to a patient or user to facilitate desired operation of a medical device, such asinfusion device 102. The various tasks performed in connection with theinteractive guidance process 200 may be performed by hardware, firmware, software executed by processing circuitry, or any combination thereof. For illustrative purposes, the following description refers to elements mentioned above in connection withFIG. 1 . In practice, portions of theinteractive guidance process 200 may be performed by different elements of thepatient guidance system 100, such as, for example, theinfusion device 102, thesensing arrangement 104, theclient device 106, theclient application 108, theremote device 114 and/or thesupport application 116. It should be appreciated that theinteractive guidance process 200 may include any number of additional or alternative tasks, the tasks need not be performed in the illustrated order and/or the tasks may be performed concurrently, and/or theinteractive guidance process 200 may be incorporated into a more comprehensive procedure or process having additional functionality not described in detail herein. Moreover, one or more of the tasks shown and described in the context ofFIG. 2 could be omitted from a practical embodiment of theinteractive guidance process 200 as long as the intended overall functionality remains intact. - The
interactive guidance process 200 begins by determining or otherwise identifying an objective associated with operation of the medical device (task 202). In this regard, theclient application 108 identifies what the patient or user of theclient device 106 is trying to accomplish or achieve using theinfusion device 102 or what feature or aspect of theinfusion device 102 is of interest to the patient. For example, theclient application 108 may generate or otherwise provide a GUI display that allows the patient to select, input, or otherwise indicate what the patient's objective is. In one embodiment, theclient application 108 generates a list of selectable GUI elements, where each of the GUI elements corresponds to a different objective, as described in greater detail below in the context ofFIG. 3 . - In other embodiments, the
client application 108 may determine what the patient's objective is based on the current state of theinfusion device 102. For example, when the patient manipulates theclient device 106 to initiate or open theclient application 108, theclient application 108 may establish a communications session with theinfusion device 102 via thenetwork 110, obtain information characterizing the current device state from theinfusion device 102 via thenetwork 110, and then determine a likely patient objective based on the current device state. In this regard, if there is an active alert or notification presented to generated by theinfusion device 102, theclient application 108 may determine the patient's objective is to resolve or understand the current alert or notification. As another example, if the delivery of fluid by theinfusion device 102 is suspended, theclient application 108 may determine the patient's objective is to enable or resume delivery. It should be noted that are numerous different potential device statuses and corresponding objectives that may be determined based thereon, and the subject matter described herein is not limited to any particular example described herein. - In other embodiments, the
client application 108 may determine what the patient's objective is based on a GUI element selected within theclient application 108. For example, theclient application 108 may include a selectable GUI element for activating a help feature, and thereby indicate a patient objective indicative of a desire to obtain explanatory information or other help understanding the GUI display currently presented by theinfusion device 102. - The
interactive guidance process 200 continues by obtaining status information indicative of the current state of the display on the medical device, the current state of the user input element(s) associated with the medical device, and the current operational settings or configuration of the medical device (tasks client application 108 receives or otherwise obtains, from theinfusion device 102 via thenetwork 110, information or data that indicates, identifies, or otherwise describes the current screen, menu, or other GUI display presented on theinfusion device 102. Theclient application 108 also receives or obtains information that indicates or identifies the state of a user input selection (or a mouse, icon, or other graphical representation thereof) on the screen, menu, or other GUI display presented on theinfusion device 102. Theclient application 108 may also obtain information pertaining to preceding user inputs or the sequence of user input selections made prior to performing theinteractive guidance process 200. Additionally, theclient application 108 obtains settings or configuration data stored or otherwise maintained onboard theinfusion device 102 pertaining to the various modes, features, or other patient-specific or patient-configurable operations supported by theinfusion device 102. In this regard, the current device settings information may indicate the modes or features supported by theinfusion device 102 that have been enabled, activated, or configured, which modes or features supported by theinfusion device 102 that have been disabled or deactivated, which patient-specific control parameters, variables, or other patient settings for which values have been defined, entered or otherwise provided, and which patient-specific control parameters, variables, or other patient settings for which no values are maintained by theinfusion device 102. - Based on the user's objective, the current user interface status, and the current device settings, the
interactive guidance process 200 generates or otherwise provides a guidance GUI display on the auxiliary device that indicates or otherwise explains how the user can achieve the objective given the current user interface status and the current device settings (task 210). For example, the guidance GUI display on theclient device 106 may provide one or more instructions or actions that the user can take from the current GUI display on theinfusion device 102 given the current state of the user input(s) associated with theinfusion device 102 and the current infusion device settings. In this regard, the guidance information provided by theapplication 108 on theclient device 106 is consistent with (or context-sensitive to) both the current infusion device operational settings and the current patient-specific settings maintained by theinfusion device 102, while also being context-sensitive with respect to the user interfaces of theinfusion device 102 to reflect the current GUI display on theinfusion device 102 and current state of user interaction with respect to that GUI display on theinfusion device 102. In other words, the guidance information is not incompatible or inconsistent with current settings maintained by theinfusion device 102, and is also not incompatible or inconsistent with the current user interface status of theinfusion device 102. - After initially providing guidance information, the
interactive guidance process 200 continues by monitoring or otherwise waiting for changes in the user interface state of the medical device, an in response to a change in the user interface state, theinteractive guidance process 200 receives or otherwise obtains updated user interface status information from the medical device and dynamically updates the guidance information to reflect the change in user interface state (tasks 210, 212, 214). In this regard, as the patient or other user interacts with the user interface element(s) associated with theinfusion device 102 to navigate through or change the GUI display presented on theinfusion device 102, the corresponding updated status information characterizing the state or location of the user input element(s) associated with theinfusion device 102 as well as the current display state of theinfusion device 102 is automatically provided to theclient application 108. For example, in one embodiment, a process or application on theinfusion device 102 that supports the communication session with theclient application 108 automatically pushes updated user interface status information to theclient application 108 whenever a new user input is received or whenever the GUI display on theinfusion device 102 changes. Thus, theclient application 108 automatically obtains the updated user interface status information substantially in real-time and dynamically refreshes or updates the GUI display on theclient device 106 to reflect the current situation on theinfusion device 102, for example, by providing updated instructions or actions that the user can take to achieve the original objective (e.g., task 202) from the updated GUI display on theinfusion device 102 in response to intervening user input(s) associated with theinfusion device 102 after the preceding guidance GUI display was originally provided. - In exemplary embodiments, as described in greater detail below in the context of
FIGS. 4-8 , the loop defined bytasks client device 106 substantially in real-time as the patient or user interacts with theinfusion device 102 until the original objective is accomplished. In this regard, once theapplication 108 determines that the updated user interface status corresponds to the user objective being accomplished (e.g., when the user has performed all the actions or instructions provided by the guidance GUI display and the display on theinfusion device 102 corresponds to the intended destination GUI display at the end of the sequence of instructed user actions), theclient application 108 may update the GUI display on theclient device 106 to reflect the objective being achieved or to revert back to a default or initial GUI display associated with the client application 108 (e.g., a home page or other landing page). - Still referring to
FIG. 2 , in accordance with one or more embodiments, theinteractive guidance process 200 may identify or otherwise determine when remote assistance or other supplementary feedback is desired by the user, and in response, transmits, uploads, or otherwise provides the user objective and status information to a remote device for analysis (tasks 218, 220). For example, the guidance GUI display provided by theclient application 108 on theclient device 106 may include a GUI element that is selectable or otherwise manipulable to initiate a customer support communications session with a customer support application 118 on aremote device 114. In this regard, theclient application 108 may store or otherwise maintain an address and/or other identification information for theremote device 116 on thesecond network 112 to support establishing a secure communications session over thenetwork 112 for uploading or otherwise transmitting information characterizing the current user objective, the current state of the display on theinfusion device 102, the current state of the user input element(s) associated with theinfusion device 102, and the current settings or configuration of theinfusion device 102. In some embodiments, theclient application 108 may be adapted to allow the user of theclient device 106 to input or otherwise provide questions that the user would like answered or otherwise explain the user's perception of the current situation and/or what the user would like to accomplish. Additionally, in some embodiments, theclient application 108 may include a GUI element (e.g., a button or the like) that enables the user of theclient device 106 to initiate a telephone call, a video call, or the like with a user of theremote device 116. - The customer support application 118 on the
remote device 116 is configured to generate or otherwise provide a GUI display on theremote device 116 that allows a remote user (e.g., a customer service specialist or the like) to review and analyze the current situation at theinfusion device 102 and provide corresponding feedback back to the user of theclient device 106 to facilitate achieving the user's objective with respect to theinfusion device 102. For example, the user of theremote device 116 may input or otherwise provide a textual explanation or feedback regarding the current status at theinfusion device 102 relative to the current user objective via the support application 118 and then select or otherwise manipulate a GUI element of the support application 118 to transmit the feedback back to theclient application 108 via the communications session over thenetwork 112. In this regard, theinteractive guidance process 200 may update the guidance GUI display based on feedback received from the remote device (task 222). For example, theclient application 108 may generate or otherwise provide the feedback received from thesupport application 116 on the guidance GUI display in lieu of the previously presented guidance information or on a separate GUI display (e.g., a pop-up window). - In some embodiments, the support session may be dynamically updated in a similar manner as described above in the context of the loop defined by
tasks infusion device 102 may be automatically pushed or uploaded to the support application 118 on theremote device 116 by the client application 108 (e.g.,tasks 214, 220), thereby enabling the user at theremote device 116 to monitor the state of theinfusion device 102 substantially in real-time as the user interacts with theinfusion device 102 and responds to the feedback from theremote device 116. As needed, the user of the support application 118 may provide updated feedback or guidance to theclient application 108, which, in turn is presented on the client device 106 (e.g., tasks 220, 222). -
FIGS. 3-8 depict an exemplary sequence of GUI displays that may be presented on an infusion device 302 (e.g., infusion device 102) and a paired auxiliary device 306 (e.g., client device 106) having a guidance application (e.g., client application 108) supporting theinteractive guidance process 200 ofFIG. 2 executing thereon. As described in greater detail below in the context ofFIGS. 12-13 , theinfusion device 302 includes a display 326 (e.g., display 1226) anduser input elements 332, 334 (e.g.,user interface elements 1232, 1234) that allow a user to navigate and interact with the GUI displays presented on thedisplay 326. Theclient device 306 also similarly includes a display having aguidance GUI display 308 generated by theclient application 108 presented thereon. - Referring to
FIG. 3 with continued reference toFIGS. 1-2 ,FIG. 3 depicts a scenario where theinfusion device 302 is presenting the main orprimary GUI display 304 for the infusion device 302 (e.g., the “Home Screen”). For example, themain GUI display 304 may include standard graphical icons for the current date, time, and other physical device status information (e.g., battery level, network connectivity, fluid remaining in the reservoir, and the like) along with graphical representations of the current state of the physiological condition in the body of the user based on measurement data received from a sensor (e.g., sensing arrangement 104). The user of theclient device 306 may manipulate the user input elements of thedevice 306 to initiate, execute, or otherwise open theclient application 108, which, in turn, establishes a communications session with theinfusion device 302 and obtains status information describing the current state of the display 326 (e.g., the currently displayed GUI display 304), the current state of theuser input elements 332, 334 (including the location of a pointer, mouse, or other user election on or within the currently displayed GUI display 304), and the current settings stored or maintained by theinfusion device 302 for the various modes or features supported by theinfusion device 302 and any customizable or patient-specific parameter values. Based on thecurrent GUI display 304 on theinfusion device 302 corresponding to the home screen, theclient application 108 may generate aninitial GUI display 308 that enables a user to input or otherwise provide indication of his or her objective with respect to theinfusion device 302. In this regard, theinitial GUI display 308 may include alist 310 of potential objectives that are selectable by the user. - Referring now to
FIG. 4 , in response to the user selecting an objective 312 indicative of a desire to consume a meal (or administer a corresponding meal bolus), theclient application 108 accesses the current device settings information obtained from the infusion device 302 (e.g., task 208) to verify or otherwise determine whether a bolus wizard feature has been configured or enabled by the user, and in response to determining that the current device setting information indicates the bolus wizard is not configured or enabled, theclient application 108 generates aguidance GUI display 408 that enables the user to input or otherwise provide indication of whether he or she would like to configure and enable the bolus wizard or whether he or she would like to bolus manually. - Referring now to
FIG. 5 , in response to selection of aGUI element 412 for configuring the bolus wizard, theclient application 108 revises the user objective to enabling the bolus wizard on theinfusion device 302 and then generates an updatedguidance GUI display 508 including a list or sequence of actions for the user to take using theinput elements infusion device 302 to achieve the objective of enabling the bolus wizard feature. In this regard, the updatedguidance GUI display 508 includes alist 510 of user actions ordered sequentially for reaching the bolus wizard setup screen(s) from the “Home Screen.” Theguidance GUI display 508 indicates whichuser input elements infusion device 302 should be actuated or manipulated by the user, the ordered sequence in which thoseuser input elements user input element user input element graphical indicia 512 is also presented on thelist 510 at the location of the entry for the step in the sequence that the user currently needs to perform. Additionally, entries that have been performed may be graphically deemphasized to reflect their performance and further indicate, to the user, where the user resides within the sequence of actions. As illustrated, the first entry in thelist 510 for navigating to the “Home Screen” is graphically deemphasized to reflect the current display status of thedisplay 326 and indicate, to the user, where the user resides within the sequence of actions. - Referring now to
FIGS. 6-8 , in response to a user manipulating auser input element infusion device 302, updated user interface status information is automatically pushed from theinfusion device 302 to theclient application 108 on theclient device 306 for dynamically updating the GUI display. For example, referring toFIG. 6 with reference toFIG. 5 , in response to the user actuating the center button on thedirectional pad 334 when the HomeScreen GUI display 304 is presented, theinfusion device 302 updates thedisplay 326 to present the MainMenu GUI display 604 and automatically provides updated status information to theclient application 108 on theclient device 306 that indicates the center button on thedirectional pad 334 was actuated and that the MainMenu GUI display 604 is currently presented. In response to the updated user interface status information, theclient application 108 dynamically generates an updatedguidance GUI display 608 that reflects the updated user interface status. For example, the second entry in thelist 510 for navigating to the “Main Menu” is graphically deemphasized to reflect the current display status of thedisplay 326 and the location of thegraphical indicia 512 on thelist 510 is updated indicate that the user is now on the third entry within the sequence of actions. Additionally, the entry for navigating to the “Main Menu” is updated to reflect a different user action or differentuser input element guidance GUI display 608 on theclient device 306 corresponds to the state of theGUI display 604 that is concurrently being presented on thedisplay 326 of theinfusion device 302, thereby allowing the user to divert his or her attention seamlessly from thedisplay 326 of theinfusion device 302 to theguidance GUI display 608 on theclient device 306 and back to theinfusion device 302, while the dynamic updating of thegraphical indicia 512 and other guidance information allows the user to keep track of real-time progress on theinfusion device 302 when viewing theclient device 306. - Referring to
FIG. 7 with reference toFIG. 6 , in response to the user manipulating thedirectional pad 334 to navigate through the MainMenu GUI display 604, theinfusion device 302 automatically provides updated user interface status information to theclient application 108 that indicates the current userinput selection location 704 within the MainMenu GUI display 604. In response to the updateduser input state 704, theclient application 108 dynamically generates an updatedguidance GUI display 708 that reflects a decreased number of user actions with respect to thedirectional pad 334 for achieving the user's objective from the currentuser input state 704. For example, after the user has actuated the down direction of thedirectional pad 334, the third entry in thelist 510 for navigating to the “Options Menu” is updated (relative to guidance GUI display 608) to reflect that the user only needs to actuate the down direction of thedirectional pad 334 three more times instead of the original number of six to reach the “Options Menu” from thecurrent selection location 704 of “Audio Options” within the Main Menu. - Referring to
FIG. 8 with reference toFIG. 7 , as the user manipulates thedirectional pad 334 to reach the “Options Menu” within the MainMenu GUI display 604, theinfusion device 302 automatically provides updated user interface status information to theclient application 108. In response to the updated userinput selection location 804 corresponding to the “Options Menu,” theclient application 108 dynamically generates an updatedguidance GUI display 808 to reflect a different user action. For example, after the user has actuated the down direction of thedirectional pad 334 six times, the third entry in thelist 510 for navigating to the “Options Menu” is updated (relative to guidance GUI displays 508, 608, 708) to reflect that the user only needs to actuate the center button of thedirectional pad 334 to navigate from the MainMenu GUI display 604 to the Options Menu GUI display. Once the center button is actuated, the third entry in thelist 510 for navigating to the “Options Menu” is graphically deemphasized to indicate that the user is now on the fourth entry within the sequence of actions as well as being updated to reflect a different user action or differentuser input element Menu GUI display 604 from the Options Menu GUI display in a similar manner as described above. The position of thegraphical indicia 512 within thelist 510 is also updated to horizontally align with the fourth entry in thelist 510. It should be noted that if the user actuates the down direction of thedirectional pad 334 an excessive amount of times and passes the “Options Menu” within the MainMenu GUI display 604, the third entry in thelist 510 for navigating to the “Options Menu” is updated (relative to guidance GUI displays 508, 608, 708) to reflect that the user only needs to actuate the up direction of thedirectional pad 334 to navigate to the Options Menu GUI display. In this manner, the likelihood of the user proceeding to an incorrect GUI display may be reduced. -
FIGS. 9-10 depict another exemplary sequence of GUI displays that may be presented on theclient device 306 in concert with theinfusion device 302 and theinteractive guidance process 200 ofFIG. 2 . Referring toFIG. 9 , in a similar manner as described above in the context ofFIGS. 3-4 , in response to the user selecting an objective 312 indicative of a desire to consume a meal (or administer a corresponding meal bolus), theclient application 108 accesses the current device settings information obtained from the infusion device 302 (e.g., task 208) to verify or otherwise determine whether a bolus wizard feature has been configured or enabled by the user. In the illustrated embodiment, in response to determining that the current device settings indicate the bolus wizard is configured and enabled, theclient application 108 generates a guidance GUI display 908 that enables the user to input or otherwise provide indication of whether he or she would like to utilize the bolus wizard or whether he or she would like to bolus manually. - Referring now to
FIG. 10 , in response to selection of aGUI element 912 for using the bolus wizard, theclient application 108 generates an updatedguidance GUI display 1008 to reflect the user objective of using the bolus wizard. In this regard, the updatedguidance GUI display 1008 includes alist 1010 of user actions ordered sequentially for using the bolus wizard. In this regard,FIG. 10 depicts a scenario after the user has navigated from the HomeScreen GUI display 304 to the MainMenu GUI display 604, with the first entry in thelist 1010 for navigating to the “Home Screen” and the second entry in thelist 1010 for navigating to the “Main Menu” being graphically deemphasized to reflect the current state of thedisplay 326 in concert with the position of thegraphical indicia 512 being updated based on the updated userinput selection location 1004 to indicate the user is on the third entry in thelist 1010. As illustrated, thelist 1010 of actions presented on theguidance GUI display 1008 instructs the user how to further navigate from the Main Menu GUI display to the Bolus Menu GUI display, into the Bolus Wizard GUI display, and from there, what inputs the user should provide and the order in which the user should provide them to achieve delivery of a bolus of fluid using the bolus wizard feature. - While the above examples describe enabling or using a feature of the
infusion device interactive guidance process 200 may be similarly employed for resolving active alerts, alarms, notifications, or other aspects of theinfusion device client application 108 may automatically determine the patient's objective is to resolve or understand the current alert or notification and provide a corresponding guidance GUI display that explains the sequence of user actions that may be taken to resolve the alert. That said, the guidance GUI display may also include one or more GUI elements that allow the user to change or modify the user objective from what was automatically determined by theclient application 108 based on the current display status information. In a similar manner, if delivery of fluid by theinfusion device client application 108 may automatically determine the patient's objective is to enable or resume that particular operating mode and provide a corresponding guidance GUI display, which, in turn, may be modified or changed by the user if desired. In yet other embodiments, the when the patient's objective is to obtain general help or explanatory information regarding the GUI display currently presented by theinfusion device 102, theclient application 108 may provide a guidance GUI display that depicts a real-time representation of the GUI display that the pump is currently presenting with callouts, interactive labels, or the like describing what each GUI element on the pump GUI display means or does or other explanatory information regarding the current pump GUI display. Additionally, although not illustrated inFIGS. 3-10 , some embodiments of theclient application 108 may include a selectable GUI element outside of the list of user actions that allows the user of theclient device FIG. 2 . -
FIG. 11 depicts one exemplary embodiment of aninfusion system 1100 suitable for use with thepatient guidance system 100 ofFIG. 1 in conjunction with theinteractive guidance process 200 ofFIGS. 2-10 . Theinfusion system 1100 includes, without limitation, a fluid infusion device (or infusion pump) 1102 (e.g.,infusion device 102, 302), a sensing arrangement 1104 (e.g., sensing arrangement 104), a command control device (CCD) 1106, and acomputer 1108, which could be realized as any one of thecomputing devices CCD 1106 is realized as aclient device computer 1108 is realized asremote device 114. The components of aninfusion system 1100 may be realized using different platforms, designs, and configurations, and the embodiment shown inFIG. 11 is not exhaustive or limiting. In practice, theinfusion device 1102 and thesensing arrangement 1104 are secured at desired locations on the body of a user (or patient), as illustrated inFIG. 11 . In this regard, the locations at which theinfusion device 1102 and thesensing arrangement 1104 are secured to the body of the user inFIG. 11 are provided only as a representative, non-limiting, example. The elements of theinfusion system 1100 may be similar to those described in U.S. Pat. No. 8,674,288, the subject matter of which is hereby incorporated by reference in its entirety. - In the illustrated embodiment of
FIG. 11 , theinfusion device 1102 is designed as a portable medical device suitable for infusing a fluid, a liquid, a gel, or other agent into the body of a user. In exemplary embodiments, the infused fluid is insulin, although many other fluids may be administered through infusion such as, but not limited to, HIV drugs, drugs to treat pulmonary hypertension, iron chelation drugs, pain medications, anti-cancer treatments, medications, vitamins, hormones, or the like. In some embodiments, the fluid may include a nutritional supplement, a dye, a tracing medium, a saline medium, a hydration medium, or the like. - The
sensing arrangement 1104 generally represents the components of theinfusion system 1100 configured to sense, detect, measure or otherwise quantify a condition of the user, and may include a sensor, a monitor, or the like, for providing data indicative of the condition that is sensed, detected, measured or otherwise monitored by the sensing arrangement. In this regard, thesensing arrangement 1104 may include electronics and enzymes reactive to a biological or physiological condition of the user, such as a blood glucose level, or the like, and provide data indicative of the blood glucose level to theinfusion device 1102, theCCD 1106 and/or thecomputer 1108. For example, theinfusion device 1102, theCCD 1106 and/or thecomputer 1108 may include a display for presenting information or data to the user based on the sensor data received from thesensing arrangement 1104, such as, for example, a current glucose level of the user, a graph or chart of the user's glucose level versus time, device status indicators, alert messages, or the like. In other embodiments, theinfusion device 1102, theCCD 1106 and/or thecomputer 1108 may include electronics and software that are configured to analyze sensor data and operate theinfusion device 1102 to deliver fluid to the body of the user based on the sensor data and/or preprogrammed delivery routines. Thus, in exemplary embodiments, one or more of theinfusion device 1102, thesensing arrangement 1104, theCCD 1106, and/or thecomputer 1108 includes a transmitter, a receiver, and/or other transceiver electronics that allow for communication with other components of theinfusion system 1100, so that thesensing arrangement 1104 may transmit sensor data or monitor data to one or more of theinfusion device 1102, theCCD 1106 and/or thecomputer 1108. - Still referring to
FIG. 11 , in various embodiments, thesensing arrangement 1104 may be secured to the body of the user or embedded in the body of the user at a location that is remote from the location at which theinfusion device 1102 is secured to the body of the user. In various other embodiments, thesensing arrangement 1104 may be incorporated within theinfusion device 1102. In other embodiments, thesensing arrangement 1104 may be separate and apart from theinfusion device 1102, and may be, for example, part of theCCD 1106. In such embodiments, thesensing arrangement 1104 may be configured to receive a biological sample, analyte, or the like, to measure a condition of the user. - In various embodiments, the
CCD 1106 and/or thecomputer 1108 may include electronics and other components configured to perform processing, delivery routine storage, and to control theinfusion device 1102 in a manner that is influenced by sensor data measured by and/or received from thesensing arrangement 1104. By including control functions in theCCD 1106 and/or thecomputer 1108, theinfusion device 1102 may be made with more simplified electronics. However, in other embodiments, theinfusion device 1102 may include all control functions, and may operate without theCCD 1106 and/or thecomputer 1108. In various embodiments, theCCD 1106 may be a portable electronic device. In addition, in various embodiments, theinfusion device 1102 and/or thesensing arrangement 1104 may be configured to transmit data to theCCD 1106 and/or thecomputer 1108 for display or processing of the data by theCCD 1106 and/or thecomputer 1108. - In some embodiments, the
CCD 1106 and/or thecomputer 1108 may provide information to the user that facilitates the user's subsequent use of theinfusion device 1102. For example, theCCD 1106 may provide information to the user to allow the user to determine the rate or dose of medication to be administered into the user's body. In other embodiments, theCCD 1106 may provide information to theinfusion device 1102 to autonomously control the rate or dose of medication administered into the body of the user. In some embodiments, thesensing arrangement 1104 may be integrated into theCCD 1106. Such embodiments may allow the user to monitor a condition by providing, for example, a sample of his or her blood to thesensing arrangement 1104 to assess his or her condition. In some embodiments, thesensing arrangement 1104 and theCCD 1106 may be used for determining glucose levels in the blood and/or body fluids of the user without the use of, or necessity of, a wire or cable connection between theinfusion device 1102 and thesensing arrangement 1104 and/or theCCD 1106. - In one or more exemplary embodiments, the
sensing arrangement 1104 and/or theinfusion device 1102 are cooperatively configured to utilize a closed-loop system for delivering fluid to the user. Examples of sensing devices and/or infusion pumps utilizing closed-loop systems may be found at, but are not limited to, the following U.S. Pat. Nos. 6,088,608, 6,119,028, 6,589,229, 6,740,072, 6,827,702, 7,323,142, and 7,402,153, all of which are incorporated herein by reference in their entirety. In such embodiments, thesensing arrangement 1104 is configured to sense or measure a condition of the user, such as, blood glucose level or the like. Theinfusion device 1102 is configured to deliver fluid in response to the condition sensed by thesensing arrangement 1104. In turn, thesensing arrangement 1104 continues to sense or otherwise quantify a current condition of the user, thereby allowing theinfusion device 1102 to deliver fluid continuously in response to the condition currently (or most recently) sensed by thesensing arrangement 1104 indefinitely. In some embodiments, thesensing arrangement 1104 and/or theinfusion device 1102 may be configured to utilize the closed-loop system only for a portion of the day, for example only when the user is asleep or awake. -
FIGS. 12-14 depict one exemplary embodiment of a fluid infusion device 1200 (or alternatively, infusion pump) suitable for use as aninfusion device FIGS. 1-11 . Thefluid infusion device 1200 is a portable medical device designed to be carried or worn by a patient (or user), and thefluid infusion device 1200 may leverage any number of conventional features, components, elements, and characteristics of existing fluid infusion devices, such as, for example, some of the features, components, elements, and/or characteristics described in U.S. Pat. Nos. 6,485,465 and 7,621,893. It should be appreciated thatFIGS. 12-14 depict some aspects of theinfusion device 1200 in a simplified manner; in practice, theinfusion device 1200 could include additional elements, features, or components that are not shown or described in detail herein. - As best illustrated in
FIGS. 12-13 , the illustrated embodiment of thefluid infusion device 1200 includes ahousing 1202 adapted to receive a fluid-containingreservoir 1205. Anopening 1220 in thehousing 1202 accommodates a fitting 1223 (or cap) for thereservoir 1205, with the fitting 1223 being configured to mate or otherwise interface withtubing 1221 of aninfusion set 1225 that provides a fluid path to/from the body of the user. In this manner, fluid communication from the interior of thereservoir 1205 to the user is established via thetubing 1221. The illustratedfluid infusion device 1200 includes a human-machine interface (HMI) 1230 (or user interface) that includeselements display element 1226, such as a liquid crystal display (LCD) or another suitable display element, that can be used to present various types of information or data to the user, such as, without limitation: the current glucose level of the patient; the time; a graph or chart of the patient's glucose level versus time; device status indicators; etc. - The
housing 1202 is formed from a substantially rigid material having a hollow interior 1014 adapted to allow anelectronics assembly 1204, a sliding member (or slide) 1206, adrive system 1208, asensor assembly 1210, and a drivesystem capping member 1212 to be disposed therein in addition to thereservoir 1205, with the contents of thehousing 1202 being enclosed by ahousing capping member 1216. Theopening 1220, theslide 1206, and thedrive system 1208 are coaxially aligned in an axial direction (indicated by arrow 1218), whereby thedrive system 1208 facilitates linear displacement of theslide 1206 in theaxial direction 1218 to dispense fluid from the reservoir 1205 (after thereservoir 1205 has been inserted into opening 1220), with thesensor assembly 1210 being configured to measure axial forces (e.g., forces aligned with the axial direction 1218) exerted on thesensor assembly 1210 responsive to operating thedrive system 1208 to displace theslide 1206. In various embodiments, thesensor assembly 1210 may be utilized to detect one or more of the following: an occlusion in a fluid path that slows, prevents, or otherwise degrades fluid delivery from thereservoir 1205 to a user's body; when thereservoir 1205 is empty; when theslide 1206 is properly seated with thereservoir 1205; when a fluid dose has been delivered; when theinfusion pump 1200 is subjected to shock or vibration; when theinfusion pump 1200 requires maintenance. - Depending on the embodiment, the fluid-containing
reservoir 1205 may be realized as a syringe, a vial, a cartridge, a bag, or the like. In certain embodiments, the infused fluid is insulin, although many other fluids may be administered through infusion such as, but not limited to, HIV drugs, drugs to treat pulmonary hypertension, iron chelation drugs, pain medications, anti-cancer treatments, medications, vitamins, hormones, or the like. As best illustrated inFIGS. 13-14 , thereservoir 1205 typically includes areservoir barrel 1219 that contains the fluid and is concentrically and/or coaxially aligned with the slide 1206 (e.g., in the axial direction 1218) when thereservoir 1205 is inserted into theinfusion pump 1200. The end of thereservoir 1205 proximate theopening 1220 may include or otherwise mate with the fitting 1223, which secures thereservoir 1205 in thehousing 1202 and prevents displacement of thereservoir 1205 in theaxial direction 1218 with respect to thehousing 1202 after thereservoir 1205 is inserted into thehousing 1202. As described above, the fitting 1223 extends from (or through) theopening 1220 of thehousing 1202 and mates withtubing 1221 to establish fluid communication from the interior of the reservoir 1205 (e.g., reservoir barrel 1219) to the user via thetubing 1221 andinfusion set 1225. The opposing end of thereservoir 1205 proximate theslide 1206 includes a plunger 1217 (or stopper) positioned to push fluid from inside thebarrel 1219 of thereservoir 1205 along a fluid path throughtubing 1221 to a user. Theslide 1206 is configured to mechanically couple or otherwise engage with theplunger 1217, thereby becoming seated with theplunger 1217 and/orreservoir 1205. Fluid is forced from thereservoir 1205 viatubing 1221 as thedrive system 1208 is operated to displace theslide 1206 in theaxial direction 1218 toward theopening 1220 in thehousing 1202. - In the illustrated embodiment of
FIGS. 13-14 , thedrive system 1208 includes amotor assembly 1207 and adrive screw 1209. Themotor assembly 1207 includes a motor that is coupled to drive train components of thedrive system 1208 that are configured to convert rotational motor motion to a translational displacement of theslide 1206 in theaxial direction 1218, and thereby engaging and displacing theplunger 1217 of thereservoir 1205 in theaxial direction 1218. In some embodiments, themotor assembly 1207 may also be powered to translate theslide 1206 in the opposing direction (e.g., the direction opposite direction 1218) to retract and/or detach from thereservoir 1205 to allow thereservoir 1205 to be replaced. In exemplary embodiments, themotor assembly 1207 includes a brushless DC (BLDC) motor having one or more permanent magnets mounted, affixed, or otherwise disposed on its rotor. However, the subject matter described herein is not necessarily limited to use with BLDC motors, and in alternative embodiments, the motor may be realized as a solenoid motor, an AC motor, a stepper motor, a piezoelectric caterpillar drive, a shape memory actuator drive, an electrochemical gas cell, a thermally driven gas cell, a bimetallic actuator, or the like. The drive train components may comprise one or more lead screws, cams, ratchets, jacks, pulleys, pawls, clamps, gears, nuts, slides, bearings, levers, beams, stoppers, plungers, sliders, brackets, guides, bearings, supports, bellows, caps, diaphragms, bags, heaters, or the like. In this regard, although the illustrated embodiment of the infusion pump utilizes a coaxially aligned drive train, the motor could be arranged in an offset or otherwise non-coaxial manner, relative to the longitudinal axis of thereservoir 1205. - As best shown in
FIG. 14 , thedrive screw 1209 mates withthreads 1402 internal to theslide 1206. When themotor assembly 1207 is powered and operated, thedrive screw 1209 rotates, and theslide 1206 is forced to translate in theaxial direction 1218. In an exemplary embodiment, theinfusion pump 1200 includes asleeve 1211 to prevent theslide 1206 from rotating when thedrive screw 1209 of thedrive system 1208 rotates. Thus, rotation of thedrive screw 1209 causes theslide 1206 to extend or retract relative to thedrive motor assembly 1207. When the fluid infusion device is assembled and operational, theslide 1206 contacts theplunger 1217 to engage thereservoir 1205 and control delivery of fluid from theinfusion pump 1200. In an exemplary embodiment, theshoulder portion 1215 of theslide 1206 contacts or otherwise engages theplunger 1217 to displace theplunger 1217 in theaxial direction 1218. In alternative embodiments, theslide 1206 may include a threadedtip 1213 capable of being detachably engaged withinternal threads 1404 on theplunger 1217 of thereservoir 1205, as described in detail in U.S. Pat. Nos. 6,248,093 and 6,485,465, which are incorporated by reference herein. - As illustrated in
FIG. 13 , theelectronics assembly 1204 includescontrol electronics 1224 coupled to thedisplay element 1226, with thehousing 1202 including atransparent window portion 1228 that is aligned with thedisplay element 1226 to allow thedisplay 1226 to be viewed by the user when theelectronics assembly 1204 is disposed within the interior 1014 of thehousing 1202. Thecontrol electronics 1224 generally represent the hardware, firmware, processing logic and/or software (or combinations thereof) configured to control operation of themotor assembly 1207 and/ordrive system 1208. Whether such functionality is implemented as hardware, firmware, a state machine, or software depends upon the particular application and design constraints imposed on the embodiment. Those familiar with the concepts described here may implement such functionality in a suitable manner for each particular application, but such implementation decisions should not be interpreted as being restrictive or limiting. In an exemplary embodiment, thecontrol electronics 1224 includes one or more programmable controllers that may be programmed to control operation of theinfusion pump 1200. - The
motor assembly 1207 includes one or moreelectrical leads 1236 adapted to be electrically coupled to theelectronics assembly 1204 to establish communication between thecontrol electronics 1224 and themotor assembly 1207. In response to command signals from thecontrol electronics 1224 that operate a motor driver (e.g., a power converter) to regulate the amount of power supplied to the motor from a power supply, the motor actuates the drive train components of thedrive system 1208 to displace theslide 1206 in theaxial direction 1218 to force fluid from thereservoir 1205 along a fluid path (includingtubing 1221 and an infusion set), thereby administering doses of the fluid contained in thereservoir 1205 into the user's body. Preferably, the power supply is realized one or more batteries contained within thehousing 1202. Alternatively, the power supply may be a solar panel, capacitor, AC or DC power supplied through a power cord, or the like. In some embodiments, thecontrol electronics 1224 may operate the motor of themotor assembly 1207 and/ordrive system 1208 in a stepwise manner, typically on an intermittent basis; to administer discrete precise doses of the fluid to the user according to programmed delivery profiles. - Referring to
FIGS. 12-14 , as described above, theuser interface 1230 includes HMI elements, such asbuttons 1232 and adirectional pad 1234, that are formed on a graphic keypad overlay 1231 that overlies akeypad assembly 1233, which includes features corresponding to thebuttons 1232,directional pad 1234 or other user interface items indicated by the graphic keypad overlay 1231. When assembled, thekeypad assembly 1233 is coupled to thecontrol electronics 1224, thereby allowing theHMI elements control electronics 1224 and control operation of theinfusion pump 1200, for example, to administer a bolus of insulin, to change therapy settings, to change user preferences, to select display features, to set or disable alarms and reminders, and the like. In this regard, thecontrol electronics 1224 maintains and/or provides information to thedisplay 1226 regarding program parameters, delivery profiles, pump operation, alarms, warnings, statuses, or the like, which may be adjusted using theHMI elements HMI elements display 1226 may be realized as a touch screen or touch-sensitive display, and in such embodiments, the features and/or functionality of theHMI elements display 1226 and theHMI 1230 may not be present. In some embodiments, theelectronics assembly 1204 may also include alert generating elements coupled to thecontrol electronics 1224 and suitably configured to generate one or more types of feedback, such as, without limitation: audible feedback; visual feedback; haptic (physical) feedback; or the like. - Referring to
FIGS. 13-14 , in accordance with one or more embodiments, thesensor assembly 1210 includes aback plate structure 1250 and aloading element 1260. Theloading element 1260 is disposed between the cappingmember 1212 and abeam structure 1270 that includes one or more beams having sensing elements disposed thereon that are influenced by compressive force applied to thesensor assembly 1210 that deflects the one or more beams, as described in greater detail in U.S. Pat. No. 8,474,332, which is incorporated by reference herein. In exemplary embodiments, theback plate structure 1250 is affixed, adhered, mounted, or otherwise mechanically coupled to thebottom surface 1238 of thedrive system 1208 such that theback plate structure 1250 resides between thebottom surface 1238 of thedrive system 1208 and thehousing cap 1216. The drivesystem capping member 1212 is contoured to accommodate and conform to the bottom of thesensor assembly 1210 and thedrive system 1208. The drivesystem capping member 1212 may be affixed to the interior of thehousing 1202 to prevent displacement of thesensor assembly 1210 in the direction opposite the direction of force provided by the drive system 1208 (e.g., the direction opposite direction 1218). Thus, thesensor assembly 1210 is positioned between themotor assembly 1207 and secured by the cappingmember 1212, which prevents displacement of thesensor assembly 1210 in a downward direction opposite the direction ofarrow 1218, such that thesensor assembly 1210 is subjected to a reactionary compressive force when thedrive system 1208 and/ormotor assembly 1207 is operated to displace theslide 1206 in theaxial direction 1218 in opposition to the fluid pressure in thereservoir 1205. Under normal operating conditions, the compressive force applied to thesensor assembly 1210 is correlated with the fluid pressure in thereservoir 1205. As shown,electrical leads 1240 are adapted to electrically couple the sensing elements of thesensor assembly 1210 to theelectronics assembly 1204 to establish communication to thecontrol electronics 1224, wherein thecontrol electronics 1224 are configured to measure, receive, or otherwise obtain electrical signals from the sensing elements of thesensor assembly 1210 that are indicative of the force applied by thedrive system 1208 in theaxial direction 1218. -
FIG. 15 depicts an exemplary embodiment of amedical device 1500 suitable for use as theinfusion device interactive guidance process 200 ofFIGS. 2-10 . The illustratedmedical device 1500 includes, without limitation, acontrol module 1502, acommunications interface 1504, adisplay device 1506, auser interface 1508, and a data storage element (or memory) 1510. Thecontrol module 1502 is coupled to thecommunications interface 1504, thememory 1510, thedisplay device 1506, and the memory 1006, and thecontrol module 1502 is suitably configured to support the operations, tasks, and/or processes described herein. It should be understood thatFIG. 15 is a simplified representation of amedical device 1500 for purposes of explanation and is not intended to limit the subject matter described herein in any way. - The
communications interface 1504 generally represents the hardware, circuitry, logic, firmware and/or other components of themedical device 1500 that are coupled to thecontrol module 1502 and configured to support communications sessions between themedical device 1500 and an auxiliary device (e.g.,devices communications interface 1504 may include or otherwise be coupled to one or more transceiver modules capable of supporting wireless communications. In other embodiments, thecommunications interface 1504 may be configured to support wired communications to/from the auxiliary device. - The
display device 1506 may be realized as any sort of electronic display capable of graphically displaying information or other data associated with operation of themedical device 1500 under control of thecontrol module 1502. Theuser interface 1508 generally includes one or more user input devices configured to allow a patient or other user to interact with themedical device 1500 and the GUI displays presented on thedisplay device 1506. Depending on the embodiment, theuser interface 1508 may include or be realized as one or more of the following user input devices: a keypad, touchpad, keyboard, mouse, touch panel (or touchscreen), joystick, knob, line select key or another suitable device adapted to receive input from a user, such as a microphone, audio transducer, audio sensor, or another audio input device. - The
control module 1502 generally represents the hardware, circuitry, logic, firmware and/or other component of themedical device 1500 configured to determine dosage commands for operating medical device 1500 (e.g., by operating an actuation arrangement to deliver fluid to the body of a patient) and perform various additional tasks, operations, functions and/or operations described herein. For example, in exemplary embodiments,control module 1502 implements or otherwise executes an application that supports establishing communications sessions with a guidance application on an auxiliary device and automatically pushing or uploading status information, settings information, and the like to the guidance application asynchronously or in another substantially real-time manner. Depending on the embodiment, thecontrol module 1502 may be implemented or realized with a general purpose processor, a microprocessor, a controller, a microcontroller, a state machine, a content addressable memory, an application specific integrated circuit, a field programmable gate array, any suitable programmable logic device, discrete gate or transistor logic, discrete hardware components, or any combination thereof, designed to perform the functions described herein. In this regard, the steps of a method or algorithm described in connection with the embodiments disclosed herein may be embodied directly in hardware, in firmware, in a software module executed by thecontrol module 1502, or in any practical combination thereof. In exemplary embodiments, thecontrol module 1502 includes or otherwise accesses the data storage element ormemory 1510, which may be realized using any sort of non-transitory computer-readable medium capable of storing programming instructions for execution by thecontrol module 1502. The computer-executable programming instructions, when read and executed by thecontrol module 1502, cause thecontrol module 1502 to implement or otherwise generate the guidance communications application and perform tasks, operations, functions, and processes described herein. - In exemplary embodiments described herein, the
memory 1510 may also store or otherwise maintain settings information for themedical device 1500 including, but not limited to, data indicating which modes or features of themedical device 1500 have been configured, data indicating which modes or features of themedical device 1500 have not been configured, data indicating which modes or features of themedical device 1500 are enabled or activated, data indicating which modes or features of themedical device 1500 have been disabled or deactivated, variables, parameters, or other values that have been programmed, configured, entered, or otherwise established for use by a particular mode or feature of themedical device 1500, and any patient-specific variables, parameters, or other values that have been programmed, configured, entered or otherwise established for use by a particular mode or feature of themedical device 1500. In this regard, the settings information may include configuration data for an operating mode of themedical device 1500, configuration data for a feature of themedical device 1500, or values or data for other patient-specific settings, parameters, or variables. For example, for an infusion device, the settings information could include a value for a basal rate, a patient-specific insulin sensitivity factor, a patient-specific insulin-to-carbohydrate ratio, a patient-specific total daily insulin requirement, or the like. - As described above in the context of
FIGS. 2-10 , in exemplary embodiments, in response to establishing a communications session with an auxiliary device via thecommunications interface 1504, the control module 1502 (or the guidance communications application executing thereon) is configured to identify or otherwise obtain status information characterizing the current state of thedisplay device 1506 and theuser interface 1508 and the settings information stored by thememory 1510 and transmit the settings information and the status information to the auxiliary device via the communications session. Thereafter, in response to receiving a user input via theuser interface 1508, thecontrol module 1502 automatically identifies or obtains updated status information characterizing the updated state of thedisplay device 1506 and theuser interface 1508 responsive to the user input and automatically pushes, uploads, or otherwise transmits the updated status information to the auxiliary device, which, in turn, allows the auxiliary device to dynamically update any guidance information presented to a user at the auxiliary device. For example, as described above, the guidance information may include a sequence of one or more user actions with respect to theuser interface 1508 for operating themedical device 1500 to deliver a bolus of fluid, configuring or enabling an operating mode or feature of the medical device 1500 (e.g., a closed-loop operating mode, a bolus wizard feature, or the like), programming patient-specific variables, parameters, or other settings into themedical device 1500, and/or the like, with the sequence of user actions being dynamically updated to reflect or distinguish those user actions that have already been performed. - For the sake of brevity, conventional techniques related to glucose sensing and/or monitoring, glucose regulation, communications networks, sessions, and security, graphical user interfaces, menus and navigation thereof, and other functional aspects of the subject matter may not be described in detail herein. In addition, certain terminology may also be used in the herein for the purpose of reference only, and thus is not intended to be limiting. For example, terms such as “first”, “second”, and other such numerical terms referring to structures do not imply a sequence or order unless clearly indicated by the context. The foregoing description may also refer to elements or nodes or features being “connected” or “coupled” together. As used herein, unless expressly stated otherwise, “coupled” means that one element/node/feature is directly or indirectly joined to (or directly or indirectly communicates with) another element/node/feature, and not necessarily mechanically.
- While at least one exemplary embodiment has been presented in the foregoing detailed description, it should be appreciated that a vast number of variations exist. It should also be appreciated that the exemplary embodiment or embodiments described herein are not intended to limit the scope, applicability, or configuration of the claimed subject matter in any way. For example, the subject matter described herein is not necessarily limited to the infusion devices and related systems described herein. Moreover, the foregoing detailed description will provide those skilled in the art with a convenient road map for implementing the described embodiment or embodiments. It should be understood that various changes can be made in the function and arrangement of elements without departing from the scope defined by the claims, which includes known equivalents and foreseeable equivalents at the time of filing this patent application. Accordingly, details of the exemplary embodiments or other limitations described above should not be read into the claims absent a clear intention to the contrary.
Claims (20)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/362,642 US20180150614A1 (en) | 2016-11-28 | 2016-11-28 | Interactive patient guidance for medical devices |
US17/930,391 US12115339B2 (en) | 2016-11-28 | 2022-09-07 | Interactive guidance for medical devices |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/362,642 US20180150614A1 (en) | 2016-11-28 | 2016-11-28 | Interactive patient guidance for medical devices |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/930,391 Continuation US12115339B2 (en) | 2016-11-28 | 2022-09-07 | Interactive guidance for medical devices |
Publications (1)
Publication Number | Publication Date |
---|---|
US20180150614A1 true US20180150614A1 (en) | 2018-05-31 |
Family
ID=62190304
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/362,642 Abandoned US20180150614A1 (en) | 2016-11-28 | 2016-11-28 | Interactive patient guidance for medical devices |
US17/930,391 Active US12115339B2 (en) | 2016-11-28 | 2022-09-07 | Interactive guidance for medical devices |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/930,391 Active US12115339B2 (en) | 2016-11-28 | 2022-09-07 | Interactive guidance for medical devices |
Country Status (1)
Country | Link |
---|---|
US (2) | US20180150614A1 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160038665A1 (en) * | 2013-03-15 | 2016-02-11 | Gambro Lundia Ab | Extracorporeal blood treatment fluids interface |
USD836769S1 (en) | 2016-12-12 | 2018-12-25 | Bigfoot Biomedical, Inc. | Insulin delivery controller |
USD839294S1 (en) | 2017-06-16 | 2019-01-29 | Bigfoot Biomedical, Inc. | Display screen with graphical user interface for closed-loop medication delivery |
US10426896B2 (en) | 2016-09-27 | 2019-10-01 | Bigfoot Biomedical, Inc. | Medicine injection and disease management systems, devices, and methods |
US20190311798A1 (en) * | 2018-04-10 | 2019-10-10 | Sutter Health | Computing Devices with Improved User Interfaces for Applications |
USD863343S1 (en) | 2017-09-27 | 2019-10-15 | Bigfoot Biomedical, Inc. | Display screen or portion thereof with graphical user interface associated with insulin delivery |
WO2020037471A1 (en) * | 2018-08-20 | 2020-02-27 | 深圳迈瑞科技有限公司 | Monitoring information output method, infusion pumps, display device, and storage medium |
US11096624B2 (en) | 2016-12-12 | 2021-08-24 | Bigfoot Biomedical, Inc. | Alarms and alerts for medication delivery devices and systems |
US11385769B2 (en) | 2014-03-31 | 2022-07-12 | Gambro Lundia Ab | Extracorporeal blood treatment flow rate adjustment |
US11389088B2 (en) | 2017-07-13 | 2022-07-19 | Bigfoot Biomedical, Inc. | Multi-scale display of blood glucose information |
US11789962B1 (en) * | 2020-02-07 | 2023-10-17 | Hitps Llc | Systems and methods for interaction between multiple computing devices to process data records |
US12115339B2 (en) | 2016-11-28 | 2024-10-15 | Medtronic Minimed, Inc. | Interactive guidance for medical devices |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USD1013544S1 (en) | 2022-04-29 | 2024-02-06 | Biolinq Incorporated | Wearable sensor |
USD1012744S1 (en) | 2022-05-16 | 2024-01-30 | Biolinq Incorporated | Wearable sensor with illuminated display |
USD1035004S1 (en) | 2023-02-28 | 2024-07-09 | Biolinq Incorporated | Wearable sensor |
Family Cites Families (232)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5935099A (en) | 1992-09-09 | 1999-08-10 | Sims Deltec, Inc. | Drug pump systems and methods |
US5338157B1 (en) | 1992-09-09 | 1999-11-02 | Sims Deltec Inc | Systems and methods for communicating with ambulat |
US3631847A (en) | 1966-03-04 | 1972-01-04 | James C Hobbs | Method and apparatus for injecting fluid into the vascular system |
FR2385406A1 (en) | 1977-03-28 | 1978-10-27 | Akzo Nv | ARTIFICIAL KIDNEY |
DE2758467C2 (en) | 1977-12-28 | 1985-04-04 | Siemens AG, 1000 Berlin und 8000 München | Device for the pre-programmable infusion of liquids |
US4559037A (en) | 1977-12-28 | 1985-12-17 | Siemens Aktiengesellschaft | Device for the pre-programmable infusion of liquids |
DE2758368C2 (en) | 1977-12-28 | 1985-10-17 | Siemens AG, 1000 Berlin und 8000 München | Device for the pre-programmable infusion of liquids |
FR2444064A1 (en) | 1978-12-15 | 1980-07-11 | Sodip Sa | MIXTURE OF VINYL CHLORIDE POLYMER AND POLYETHERURETHANE WITH A TERTIARY AND / OR AMMONIUM AMINE GROUP, IN PARTICULAR FOR A CONFORMED OBJECT FOR MEDICAL USE |
US4731051A (en) | 1979-04-27 | 1988-03-15 | The Johns Hopkins University | Programmable control means for providing safe and controlled medication infusion |
US4373527B1 (en) | 1979-04-27 | 1995-06-27 | Univ Johns Hopkins | Implantable programmable medication infusion system |
DE3035670A1 (en) | 1980-09-22 | 1982-04-29 | Siemens AG, 1000 Berlin und 8000 München | DEVICE FOR INFUSING LIQUIDS IN HUMAN OR ANIMAL BODIES |
US4494950A (en) | 1982-01-19 | 1985-01-22 | The Johns Hopkins University | Plural module medication delivery system |
US4443218A (en) | 1982-09-09 | 1984-04-17 | Infusaid Corporation | Programmable implantable infusate pump |
US4826810A (en) | 1983-12-16 | 1989-05-02 | Aoki Thomas T | System and method for treating animal body tissues to improve the dietary fuel processing capabilities thereof |
US4678408A (en) | 1984-01-06 | 1987-07-07 | Pacesetter Infusion, Ltd. | Solenoid drive apparatus for an external infusion pump |
US4562751A (en) | 1984-01-06 | 1986-01-07 | Nason Clyde K | Solenoid drive apparatus for an external infusion pump |
US4685903A (en) | 1984-01-06 | 1987-08-11 | Pacesetter Infusion, Ltd. | External infusion pump apparatus |
US5100380A (en) | 1984-02-08 | 1992-03-31 | Abbott Laboratories | Remotely programmable infusion system |
US4550731A (en) | 1984-03-07 | 1985-11-05 | Cordis Corporation | Acquisition circuit for cardiac pacer |
US4542532A (en) | 1984-03-09 | 1985-09-17 | Medtronic, Inc. | Dual-antenna transceiver |
CA1254091A (en) | 1984-09-28 | 1989-05-16 | Vladimir Feingold | Implantable medication infusion system |
US4781798A (en) | 1985-04-19 | 1988-11-01 | The Regents Of The University Of California | Transparent multi-oxygen sensor array and method of using same |
US4671288A (en) | 1985-06-13 | 1987-06-09 | The Regents Of The University Of California | Electrochemical cell sensor for continuous short-term use in tissues and blood |
US5003298A (en) | 1986-01-15 | 1991-03-26 | Karel Havel | Variable color digital display for emphasizing position of decimal point |
US4731726A (en) | 1986-05-19 | 1988-03-15 | Healthware Corporation | Patient-operated glucose monitor and diabetes management system |
US4803625A (en) | 1986-06-30 | 1989-02-07 | Buddy Systems, Inc. | Personal health monitor |
EP0290683A3 (en) | 1987-05-01 | 1988-12-14 | Diva Medical Systems B.V. | Diabetes management system and apparatus |
US5011468A (en) | 1987-05-29 | 1991-04-30 | Retroperfusion Systems, Inc. | Retroperfusion and retroinfusion control apparatus, system and method |
US4809697A (en) | 1987-10-14 | 1989-03-07 | Siemens-Pacesetter, Inc. | Interactive programming and diagnostic system for use with implantable pacemaker |
US5041086A (en) | 1987-12-04 | 1991-08-20 | Pacesetter Infusion, Ltd. | Clinical configuration of multimode medication infusion system |
US5025374A (en) | 1987-12-09 | 1991-06-18 | Arch Development Corp. | Portable system for choosing pre-operative patient test |
US4998578A (en) | 1988-01-11 | 1991-03-12 | Lanxide Technology Company, Lp | Method of making metal matrix composites |
US4898578A (en) | 1988-01-26 | 1990-02-06 | Baxter International Inc. | Drug infusion system with calculator |
GB2218831A (en) | 1988-05-17 | 1989-11-22 | Mark John Newland | Personal medical apparatus |
US4982872A (en) | 1988-12-15 | 1991-01-08 | Avery Donald J | Film-encapsulated-structure container for food, beverages and other consumable products and method for making of same |
US5153827A (en) | 1989-01-30 | 1992-10-06 | Omni-Flow, Inc. | An infusion management and pumping system having an alarm handling system |
US5320725A (en) | 1989-08-02 | 1994-06-14 | E. Heller & Company | Electrode and method for the detection of hydrogen peroxide |
US5264105A (en) | 1989-08-02 | 1993-11-23 | Gregg Brian A | Enzyme electrodes |
US5264104A (en) | 1989-08-02 | 1993-11-23 | Gregg Brian A | Enzyme electrodes |
US5262035A (en) | 1989-08-02 | 1993-11-16 | E. Heller And Company | Enzyme electrodes |
US5101814A (en) | 1989-08-11 | 1992-04-07 | Palti Yoram Prof | System for monitoring and controlling blood glucose |
US5050612A (en) | 1989-09-12 | 1991-09-24 | Matsumura Kenneth N | Device for computer-assisted monitoring of the body |
US5108819A (en) | 1990-02-14 | 1992-04-28 | Eli Lilly And Company | Thin film electrical component |
US5080653A (en) | 1990-04-16 | 1992-01-14 | Pacesetter Infusion, Ltd. | Infusion pump with dual position syringe locator |
US5097122A (en) | 1990-04-16 | 1992-03-17 | Pacesetter Infusion, Ltd. | Medication infusion system having optical motion sensor to detect drive mechanism malfunction |
US5165407A (en) | 1990-04-19 | 1992-11-24 | The University Of Kansas | Implantable glucose sensor |
US5078683A (en) | 1990-05-04 | 1992-01-07 | Block Medical, Inc. | Programmable infusion system |
CA2050057A1 (en) | 1991-03-04 | 1992-09-05 | Adam Heller | Interferant eliminating biosensors |
US5593852A (en) | 1993-12-02 | 1997-01-14 | Heller; Adam | Subcutaneous glucose electrode |
US5262305A (en) | 1991-03-04 | 1993-11-16 | E. Heller & Company | Interferant eliminating biosensors |
US5247434A (en) | 1991-04-19 | 1993-09-21 | Althin Medical, Inc. | Method and apparatus for kidney dialysis |
US5322063A (en) | 1991-10-04 | 1994-06-21 | Eli Lilly And Company | Hydrophilic polyurethane membranes for electrochemical glucose sensors |
US5284140A (en) | 1992-02-11 | 1994-02-08 | Eli Lilly And Company | Acrylic copolymer membranes for biosensors |
JPH08275927A (en) | 1992-02-13 | 1996-10-22 | Seta:Kk | Homestay medical care system and medical device used in this system |
US5788669A (en) | 1995-11-22 | 1998-08-04 | Sims Deltec, Inc. | Pump tracking system |
US5376070A (en) | 1992-09-29 | 1994-12-27 | Minimed Inc. | Data transfer system for an infusion pump |
US5960403A (en) | 1992-11-17 | 1999-09-28 | Health Hero Network | Health management process control system |
US6101478A (en) | 1997-04-30 | 2000-08-08 | Health Hero Network | Multi-user remote health monitoring system |
US5918603A (en) | 1994-05-23 | 1999-07-06 | Health Hero Network, Inc. | Method for treating medical conditions using a microprocessor-based video game |
US5940801A (en) | 1994-04-26 | 1999-08-17 | Health Hero Network, Inc. | Modular microprocessor-based diagnostic measurement apparatus and method for psychological conditions |
US5913310A (en) | 1994-05-23 | 1999-06-22 | Health Hero Network, Inc. | Method for diagnosis and treatment of psychological and emotional disorders using a microprocessor-based video game |
US5997476A (en) | 1997-03-28 | 1999-12-07 | Health Hero Network, Inc. | Networked system for interactive communication and remote monitoring of individuals |
US5899855A (en) | 1992-11-17 | 1999-05-04 | Health Hero Network, Inc. | Modular microprocessor-based health monitoring system |
US5307263A (en) | 1992-11-17 | 1994-04-26 | Raya Systems, Inc. | Modular microprocessor-based health monitoring system |
US5956501A (en) | 1997-01-10 | 1999-09-21 | Health Hero Network, Inc. | Disease simulation system and method |
US5879163A (en) | 1996-06-24 | 1999-03-09 | Health Hero Network, Inc. | On-line health education and feedback system using motivational driver profile coding and automated content fulfillment |
US5897493A (en) | 1997-03-28 | 1999-04-27 | Health Hero Network, Inc. | Monitoring system for remotely querying individuals |
US5832448A (en) | 1996-10-16 | 1998-11-03 | Health Hero Network | Multiple patient monitoring system for proactive health management |
US5933136A (en) | 1996-12-23 | 1999-08-03 | Health Hero Network, Inc. | Network media access control system for encouraging patient compliance with a treatment plan |
US5371687A (en) | 1992-11-20 | 1994-12-06 | Boehringer Mannheim Corporation | Glucose test data acquisition and management system |
ZA938555B (en) | 1992-11-23 | 1994-08-02 | Lilly Co Eli | Technique to improve the performance of electrochemical sensors |
US5299571A (en) | 1993-01-22 | 1994-04-05 | Eli Lilly And Company | Apparatus and method for implantation of sensors |
US5357427A (en) | 1993-03-15 | 1994-10-18 | Digital Equipment Corporation | Remote monitoring of high-risk patients using artificial intelligence |
US5350411A (en) | 1993-06-28 | 1994-09-27 | Medtronic, Inc. | Pacemaker telemetry system |
US5368562A (en) | 1993-07-30 | 1994-11-29 | Pharmacia Deltec, Inc. | Systems and methods for operating ambulatory medical devices such as drug delivery devices |
DE4329229A1 (en) | 1993-08-25 | 1995-03-09 | Meditech Medizintechnik Gmbh | Adaptive controlled pump control, in particular for adaptive patient-controlled analgesia (APCA) |
US5497772A (en) | 1993-11-19 | 1996-03-12 | Alfred E. Mann Foundation For Scientific Research | Glucose monitoring system |
US5791344A (en) | 1993-11-19 | 1998-08-11 | Alfred E. Mann Foundation For Scientific Research | Patient monitoring system |
US5660176A (en) | 1993-12-29 | 1997-08-26 | First Opinion Corporation | Computerized medical diagnostic and treatment advice system |
US5594638A (en) | 1993-12-29 | 1997-01-14 | First Opinion Corporation | Computerized medical diagnostic system including re-enter function and sensitivity factors |
FR2716286A1 (en) | 1994-02-16 | 1995-08-18 | Debiotech Sa | Installation of remote monitoring of controllable equipment. |
US5543326A (en) | 1994-03-04 | 1996-08-06 | Heller; Adam | Biosensor including chemically modified enzymes |
US5536249A (en) | 1994-03-09 | 1996-07-16 | Visionary Medical Products, Inc. | Pen-type injector with a microprocessor and blood characteristic monitor |
US5630710A (en) | 1994-03-09 | 1997-05-20 | Baxter International Inc. | Ambulatory infusion pump |
US5391250A (en) | 1994-03-15 | 1995-02-21 | Minimed Inc. | Method of fabricating thin film sensors |
US5390671A (en) | 1994-03-15 | 1995-02-21 | Minimed Inc. | Transcutaneous sensor insertion set |
US5569186A (en) | 1994-04-25 | 1996-10-29 | Minimed Inc. | Closed loop infusion pump system with removable glucose sensor |
US5370622A (en) | 1994-04-28 | 1994-12-06 | Minimed Inc. | Proctective case for a medication infusion pump |
US5482473A (en) | 1994-05-09 | 1996-01-09 | Minimed Inc. | Flex circuit connector |
US5704366A (en) | 1994-05-23 | 1998-01-06 | Enact Health Management Systems | System for monitoring and reporting medical measurements |
US5582593A (en) | 1994-07-21 | 1996-12-10 | Hultman; Barry W. | Ambulatory medication delivery system |
US5569187A (en) | 1994-08-16 | 1996-10-29 | Texas Instruments Incorporated | Method and apparatus for wireless chemical supplying |
US5505709A (en) | 1994-09-15 | 1996-04-09 | Minimed, Inc., A Delaware Corporation | Mated infusion pump and syringe |
US5687734A (en) | 1994-10-20 | 1997-11-18 | Hewlett-Packard Company | Flexible patient monitoring system featuring a multiport transmitter |
IE72524B1 (en) | 1994-11-04 | 1997-04-23 | Elan Med Tech | Analyte-controlled liquid delivery device and analyte monitor |
US6749586B2 (en) | 1994-11-25 | 2004-06-15 | I-Flow Corporation | Remotely programmable infusion system |
US5573506A (en) | 1994-11-25 | 1996-11-12 | Block Medical, Inc. | Remotely programmable infusion system |
US5685844A (en) | 1995-01-06 | 1997-11-11 | Abbott Laboratories | Medicinal fluid pump having multiple stored protocols |
US5586553A (en) | 1995-02-16 | 1996-12-24 | Minimed Inc. | Transcutaneous sensor insertion set |
US5814015A (en) | 1995-02-24 | 1998-09-29 | Harvard Clinical Technology, Inc. | Infusion pump for at least one syringe |
US5609060A (en) | 1995-04-28 | 1997-03-11 | Dentsleeve Pty Limited | Multiple channel perfused manometry apparatus and a method of operation of such a device |
US5772635A (en) | 1995-05-15 | 1998-06-30 | Alaris Medical Systems, Inc. | Automated infusion system with dose rate calculator |
US5665065A (en) | 1995-05-26 | 1997-09-09 | Minimed Inc. | Medication infusion device with blood glucose data input |
US6018289A (en) | 1995-06-15 | 2000-01-25 | Sekura; Ronald D. | Prescription compliance device and method of using device |
US5750926A (en) | 1995-08-16 | 1998-05-12 | Alfred E. Mann Foundation For Scientific Research | Hermetically sealed electrical feedthrough for use with implantable electronic devices |
US5754111A (en) | 1995-09-20 | 1998-05-19 | Garcia; Alfredo | Medical alerting system |
US5972199A (en) | 1995-10-11 | 1999-10-26 | E. Heller & Company | Electrochemical analyte sensors using thermostable peroxidase |
US6689265B2 (en) | 1995-10-11 | 2004-02-10 | Therasense, Inc. | Electrochemical analyte sensors using thermostable soybean peroxidase |
US5665222A (en) | 1995-10-11 | 1997-09-09 | E. Heller & Company | Soybean peroxidase electrochemical sensor |
AUPN707195A0 (en) | 1995-12-12 | 1996-01-11 | University Of Melbourne, The | Field programmable intravenous infusion system |
FI118509B (en) | 1996-02-12 | 2007-12-14 | Nokia Oyj | A method and apparatus for predicting blood glucose levels in a patient |
FR2748588B1 (en) | 1996-05-07 | 1998-08-07 | Soc Et Tech Set | DEVICE COMPRISING AT LEAST ONE ARRAY OF NEURONES FOR DETERMINING THE QUANTITY OF A SUBSTANCE TO BE ADMINISTERED TO A PATIENT, IN PARTICULAR INSULIN |
US5861018A (en) | 1996-05-28 | 1999-01-19 | Telecom Medical Inc. | Ultrasound transdermal communication system and method |
US5807336A (en) | 1996-08-02 | 1998-09-15 | Sabratek Corporation | Apparatus for monitoring and/or controlling a medical device |
US5885245A (en) | 1996-08-02 | 1999-03-23 | Sabratek Corporation | Medical apparatus with remote virtual input device |
CA2271710A1 (en) | 1996-11-08 | 1998-05-14 | Linda L. Roman | System for providing comprehensive health care and support |
WO1998024358A2 (en) | 1996-12-04 | 1998-06-11 | Enact Health Management Systems | System for downloading and reporting medical information |
US6043437A (en) | 1996-12-20 | 2000-03-28 | Alfred E. Mann Foundation | Alumina insulation for coating implantable components and other microminiature devices |
US6032119A (en) | 1997-01-16 | 2000-02-29 | Health Hero Network, Inc. | Personalized display of health information |
CZ349198A3 (en) | 1997-01-31 | 1999-04-14 | Silverline Power Conversion, Llc | Uninterruptible power supply unit |
WO1998035225A1 (en) | 1997-02-06 | 1998-08-13 | E. Heller & Company | Small volume in vitro analyte sensor |
US6009339A (en) | 1997-02-27 | 1999-12-28 | Terumo Cardiovascular Systems Corporation | Blood parameter measurement device |
AU8938598A (en) | 1997-03-27 | 1999-04-23 | Medtronic, Inc. | Implantable Medical Device Remote Expert Communications System For Coordina ted Implant And Follow-Up |
US5960085A (en) | 1997-04-14 | 1999-09-28 | De La Huerga; Carlos | Security badge for automated access control and secure data gathering |
US5779665A (en) | 1997-05-08 | 1998-07-14 | Minimed Inc. | Transdermal introducer assembly |
TW357517B (en) | 1997-05-29 | 1999-05-01 | Koji Akai | Monitoring system |
US6558351B1 (en) | 1999-06-03 | 2003-05-06 | Medtronic Minimed, Inc. | Closed loop system for controlling insulin infusion |
US5954643A (en) | 1997-06-09 | 1999-09-21 | Minimid Inc. | Insertion set for a transcutaneous sensor |
AU8165498A (en) | 1997-06-23 | 1999-01-04 | Enact Health Management Systems | Improved system for downloading and reporting medical information |
US6130620A (en) | 1997-08-11 | 2000-10-10 | Electronic Monitoring Systems, Inc. | Remote monitoring system |
WO1999010801A1 (en) | 1997-08-22 | 1999-03-04 | Apex Inc. | Remote computer control system |
US5999849A (en) | 1997-09-12 | 1999-12-07 | Alfred E. Mann Foundation | Low power rectifier circuit for implantable medical device |
US6071391A (en) | 1997-09-12 | 2000-06-06 | Nok Corporation | Enzyme electrode structure |
US6259937B1 (en) | 1997-09-12 | 2001-07-10 | Alfred E. Mann Foundation | Implantable substrate sensor |
US5999848A (en) | 1997-09-12 | 1999-12-07 | Alfred E. Mann Foundation | Daisy chainable sensors and stimulators for implantation in living tissue |
US5917346A (en) | 1997-09-12 | 1999-06-29 | Alfred E. Mann Foundation | Low power current to frequency converter circuit for use in implantable sensors |
ATE345825T1 (en) | 1997-10-02 | 2006-12-15 | Micromed Technology Inc | CONTROL MODULE FOR IMPLANTABLE PUMP SYSTEM |
US6119028A (en) | 1997-10-20 | 2000-09-12 | Alfred E. Mann Foundation | Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces |
US6081736A (en) | 1997-10-20 | 2000-06-27 | Alfred E. Mann Foundation | Implantable enzyme-based monitoring systems adapted for long term use |
US6088608A (en) | 1997-10-20 | 2000-07-11 | Alfred E. Mann Foundation | Electrochemical sensor and integrity tests therefor |
FI107080B (en) | 1997-10-27 | 2001-05-31 | Nokia Mobile Phones Ltd | measuring device |
US6579690B1 (en) | 1997-12-05 | 2003-06-17 | Therasense, Inc. | Blood analyte monitoring through subcutaneous measurement |
US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
US6103033A (en) | 1998-03-04 | 2000-08-15 | Therasense, Inc. | Process for producing an electrochemical biosensor |
EP1061972A1 (en) | 1998-03-16 | 2000-12-27 | Medtronic, Inc. | Hemostatic system and components for extracorporeal circuit |
US5904708A (en) | 1998-03-19 | 1999-05-18 | Medtronic, Inc. | System and method for deriving relative physiologic signals |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6294281B1 (en) | 1998-06-17 | 2001-09-25 | Therasense, Inc. | Biological fuel cell and method |
US6558320B1 (en) | 2000-01-20 | 2003-05-06 | Medtronic Minimed, Inc. | Handheld personal data assistant (PDA) with a medical device and method of using the same |
US6554798B1 (en) | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
AU6255699A (en) | 1998-10-08 | 2000-04-26 | Minimed, Inc. | Telemetered characteristic monitor system |
US6591125B1 (en) | 2000-06-27 | 2003-07-08 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
US6338790B1 (en) | 1998-10-08 | 2002-01-15 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
US6817990B2 (en) | 1998-10-29 | 2004-11-16 | Medtronic Minimed, Inc. | Fluid reservoir piston |
US7621893B2 (en) | 1998-10-29 | 2009-11-24 | Medtronic Minimed, Inc. | Methods and apparatuses for detecting occlusions in an ambulatory infusion pump |
US6248093B1 (en) | 1998-10-29 | 2001-06-19 | Minimed Inc. | Compact pump drive system |
US20040158193A1 (en) * | 1999-02-10 | 2004-08-12 | Baxter International Inc. | Medical apparatus using selective graphical interface |
US6561978B1 (en) | 1999-02-12 | 2003-05-13 | Cygnus, Inc. | Devices and methods for frequent measurement of an analyte present in a biological system |
US6560741B1 (en) | 1999-02-24 | 2003-05-06 | Datastrip (Iom) Limited | Two-dimensional printed code for storing biometric information and integrated off-line apparatus for reading same |
US6424847B1 (en) | 1999-02-25 | 2002-07-23 | Medtronic Minimed, Inc. | Glucose monitor calibration methods |
US6360888B1 (en) | 1999-02-25 | 2002-03-26 | Minimed Inc. | Glucose sensor package system |
US6418332B1 (en) | 1999-02-25 | 2002-07-09 | Minimed | Test plug and cable for a glucose monitor |
US6752787B1 (en) | 1999-06-08 | 2004-06-22 | Medtronic Minimed, Inc., | Cost-sensitive application infusion device |
AU5747100A (en) | 1999-06-18 | 2001-01-09 | Therasense, Inc. | Mass transport limited in vivo analyte sensor |
US7247138B2 (en) | 1999-07-01 | 2007-07-24 | Medtronic Minimed, Inc. | Reusable analyte sensor site and method of using the same |
US6553263B1 (en) | 1999-07-30 | 2003-04-22 | Advanced Bionics Corporation | Implantable pulse generators using rechargeable zero-volt technology lithium-ion batteries |
US6616819B1 (en) | 1999-11-04 | 2003-09-09 | Therasense, Inc. | Small volume in vitro analyte sensor and methods |
US6605200B1 (en) | 1999-11-15 | 2003-08-12 | Therasense, Inc. | Polymeric transition metal complexes and uses thereof |
US6484045B1 (en) | 2000-02-10 | 2002-11-19 | Medtronic Minimed, Inc. | Analyte sensor and method of making the same |
US20030060765A1 (en) | 2000-02-16 | 2003-03-27 | Arthur Campbell | Infusion device menu structure and method of using the same |
US6895263B2 (en) | 2000-02-23 | 2005-05-17 | Medtronic Minimed, Inc. | Real time self-adjusting calibration algorithm |
US6485465B2 (en) | 2000-03-29 | 2002-11-26 | Medtronic Minimed, Inc. | Methods, apparatuses, and uses for infusion pump fluid pressure and force detection |
US6623501B2 (en) | 2000-04-05 | 2003-09-23 | Therasense, Inc. | Reusable ceramic skin-piercing device |
WO2001088524A1 (en) | 2000-05-12 | 2001-11-22 | Therasense, Inc. | Electrodes with multilayer membranes and methods of using and making the electrodes |
EP1316048A2 (en) | 2000-05-18 | 2003-06-04 | ALARIS Medical Systems, Inc. | Distributed remote asset and medication management drug delivery system |
US6616606B1 (en) | 2000-05-19 | 2003-09-09 | Welch Allyn Protocol, Inc. | Patient monitoring system |
US6659947B1 (en) | 2000-07-13 | 2003-12-09 | Ge Medical Systems Information Technologies, Inc. | Wireless LAN architecture for integrated time-critical and non-time-critical services within medical facilities |
US6589229B1 (en) | 2000-07-31 | 2003-07-08 | Becton, Dickinson And Company | Wearable, self-contained drug infusion device |
US20020055857A1 (en) | 2000-10-31 | 2002-05-09 | Mault James R. | Method of assisting individuals in lifestyle control programs conducive to good health |
US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
WO2002078512A2 (en) | 2001-04-02 | 2002-10-10 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
US6748250B1 (en) | 2001-04-27 | 2004-06-08 | Medoptix, Inc. | Method and system of monitoring a patient |
US6676816B2 (en) | 2001-05-11 | 2004-01-13 | Therasense, Inc. | Transition metal complexes with (pyridyl)imidazole ligands and sensors using said complexes |
US6932894B2 (en) | 2001-05-15 | 2005-08-23 | Therasense, Inc. | Biosensor membranes composed of polymers containing heterocyclic nitrogens |
WO2003001329A2 (en) | 2001-06-20 | 2003-01-03 | Power Medical Interventions, Inc. | A method and system for integrated medical tracking |
US20030208113A1 (en) | 2001-07-18 | 2003-11-06 | Mault James R | Closed loop glycemic index system |
US6747556B2 (en) | 2001-07-31 | 2004-06-08 | Medtronic Physio-Control Corp. | Method and system for locating a portable medical device |
US7025760B2 (en) | 2001-09-07 | 2006-04-11 | Medtronic Minimed, Inc. | Method and system for non-vascular sensor implantation |
US6740072B2 (en) | 2001-09-07 | 2004-05-25 | Medtronic Minimed, Inc. | System and method for providing closed loop infusion formulation delivery |
US7323142B2 (en) | 2001-09-07 | 2008-01-29 | Medtronic Minimed, Inc. | Sensor substrate and method of fabricating same |
US6671554B2 (en) | 2001-09-07 | 2003-12-30 | Medtronic Minimed, Inc. | Electronic lead for a medical implant device, method of making same, and method and apparatus for inserting same |
US6827702B2 (en) | 2001-09-07 | 2004-12-07 | Medtronic Minimed, Inc. | Safety limits for closed-loop infusion pump control |
US6728576B2 (en) | 2001-10-31 | 2004-04-27 | Medtronic, Inc. | Non-contact EKG |
US20050027182A1 (en) | 2001-12-27 | 2005-02-03 | Uzair Siddiqui | System for monitoring physiological characteristics |
US20030212379A1 (en) | 2002-02-26 | 2003-11-13 | Bylund Adam David | Systems and methods for remotely controlling medication infusion and analyte monitoring |
CA2482859C (en) | 2002-04-16 | 2010-02-09 | Carematix, Inc. | Method and apparatus for remotely monitoring the condition of a patient |
JP2005523793A (en) | 2002-04-30 | 2005-08-11 | バクスター・インターナショナル・インコーポレイテッド | System and method for identifying a data stream associated with a medical device |
US20040167465A1 (en) | 2002-04-30 | 2004-08-26 | Mihai Dan M. | System and method for medical device authentication |
US20040061232A1 (en) | 2002-09-27 | 2004-04-01 | Medtronic Minimed, Inc. | Multilayer substrate |
US7162289B2 (en) | 2002-09-27 | 2007-01-09 | Medtronic Minimed, Inc. | Method and apparatus for enhancing the integrity of an implantable sensor device |
US7736309B2 (en) | 2002-09-27 | 2010-06-15 | Medtronic Minimed, Inc. | Implantable sensor method and system |
US7138330B2 (en) | 2002-09-27 | 2006-11-21 | Medtronic Minimed, Inc. | High reliability multilayer circuit substrates and methods for their formation |
CA2501825C (en) | 2002-10-09 | 2009-12-01 | Therasense, Inc. | Fluid delivery device, system and method |
US20040074785A1 (en) | 2002-10-18 | 2004-04-22 | Holker James D. | Analyte sensors and methods for making them |
US6931328B2 (en) | 2002-11-08 | 2005-08-16 | Optiscan Biomedical Corp. | Analyte detection system with software download capabilities |
US20050038680A1 (en) | 2002-12-19 | 2005-02-17 | Mcmahon Kevin Lee | System and method for glucose monitoring |
US20040122353A1 (en) | 2002-12-19 | 2004-06-24 | Medtronic Minimed, Inc. | Relay device for transferring information between a sensor system and a fluid delivery system |
US6932584B2 (en) | 2002-12-26 | 2005-08-23 | Medtronic Minimed, Inc. | Infusion device and driving mechanism and process for same with actuator for multiple infusion uses |
US7396330B2 (en) | 2003-01-07 | 2008-07-08 | Triage Data Networks | Wireless, internet-based medical-diagnostic system |
WO2004084720A2 (en) | 2003-03-21 | 2004-10-07 | Welch Allyn, Inc. | Personal status physiologic monitor system and architecture and related monitoring methods |
US7761261B2 (en) | 2003-04-08 | 2010-07-20 | Medic4All A.G. | Portable wireless gateway for remote medical examination |
US20050055244A1 (en) * | 2003-07-18 | 2005-03-10 | Janet Mullan | Wireless medical communication system and method |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US7519408B2 (en) | 2003-11-19 | 2009-04-14 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
US20050038331A1 (en) | 2003-08-14 | 2005-02-17 | Grayson Silaski | Insertable sensor assembly having a coupled inductor communicative system |
WO2005083940A1 (en) | 2004-02-19 | 2005-09-09 | Koninklijke Philips Electronics, N.V. | Method and associated system for wireless medical monitoring and patient monitoring device |
JP2006065690A (en) | 2004-08-27 | 2006-03-09 | Ntt Docomo Inc | Device authentication apparatus, service controller, service request apparatus, device authentication method, service control method, and service request method |
US7777622B2 (en) | 2004-11-12 | 2010-08-17 | Koninklijke Philips Electronics N.V. | Message integrity for secure communication of wireless medical devices |
JP2008522459A (en) | 2004-11-16 | 2008-06-26 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Time synchronization in wireless ad hoc networks of medical devices and sensors |
US20060293571A1 (en) | 2005-06-23 | 2006-12-28 | Skanda Systems | Distributed architecture for remote patient monitoring and caring |
AU2006325783B2 (en) | 2005-12-14 | 2011-09-08 | Welch Allyn, Inc. | Medical device wireless adapter |
US20090036750A1 (en) * | 2007-05-25 | 2009-02-05 | The Charles Stark Draper Laboratory, Inc. | Integration and control of medical devices in a clinical environment |
US8311585B2 (en) * | 2007-09-28 | 2012-11-13 | Hewlett-Packard Development Company, L.P. | Synchronized helper system using paired computing device |
US8674288B2 (en) | 2010-03-24 | 2014-03-18 | Medtronic Minimed, Inc. | Motor assembly sensor capture systems and methods |
US8474332B2 (en) | 2010-10-20 | 2013-07-02 | Medtronic Minimed, Inc. | Sensor assembly and medical device incorporating same |
US9547752B2 (en) * | 2010-12-31 | 2017-01-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Automated catheter guidance system |
DE102013201546A1 (en) | 2013-01-30 | 2014-07-31 | Siemens Aktiengesellschaft | Method for determining help information, medical device, mobile application and system |
US9880528B2 (en) | 2013-08-21 | 2018-01-30 | Medtronic Minimed, Inc. | Medical devices and related updating methods and systems |
US9889257B2 (en) | 2013-08-21 | 2018-02-13 | Medtronic Minimed, Inc. | Systems and methods for updating medical devices |
US10569015B2 (en) * | 2013-12-02 | 2020-02-25 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
US9737656B2 (en) * | 2013-12-26 | 2017-08-22 | Tandem Diabetes Care, Inc. | Integration of infusion pump with remote electronic device |
US20180150614A1 (en) | 2016-11-28 | 2018-05-31 | Medtronic Minimed, Inc. | Interactive patient guidance for medical devices |
-
2016
- 2016-11-28 US US15/362,642 patent/US20180150614A1/en not_active Abandoned
-
2022
- 2022-09-07 US US17/930,391 patent/US12115339B2/en active Active
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160038665A1 (en) * | 2013-03-15 | 2016-02-11 | Gambro Lundia Ab | Extracorporeal blood treatment fluids interface |
US11385769B2 (en) | 2014-03-31 | 2022-07-12 | Gambro Lundia Ab | Extracorporeal blood treatment flow rate adjustment |
US11740767B2 (en) | 2014-03-31 | 2023-08-29 | Gambro Lundia Ab | Extracorporeal blood treatment flow rate adjustment |
US11806514B2 (en) | 2016-09-27 | 2023-11-07 | Bigfoot Biomedical, Inc. | Medicine injection and disease management systems, devices, and methods |
US11229751B2 (en) | 2016-09-27 | 2022-01-25 | Bigfoot Biomedical, Inc. | Personalizing preset meal sizes in insulin delivery system |
US10426896B2 (en) | 2016-09-27 | 2019-10-01 | Bigfoot Biomedical, Inc. | Medicine injection and disease management systems, devices, and methods |
US11957888B2 (en) | 2016-09-27 | 2024-04-16 | Bigfoot Biomedical, Inc. | Personalizing preset meal sizes in insulin delivery system |
US12115339B2 (en) | 2016-11-28 | 2024-10-15 | Medtronic Minimed, Inc. | Interactive guidance for medical devices |
US11096624B2 (en) | 2016-12-12 | 2021-08-24 | Bigfoot Biomedical, Inc. | Alarms and alerts for medication delivery devices and systems |
US12076160B2 (en) | 2016-12-12 | 2024-09-03 | Insulet Corporation | Alarms and alerts for medication delivery devices and systems |
USD836769S1 (en) | 2016-12-12 | 2018-12-25 | Bigfoot Biomedical, Inc. | Insulin delivery controller |
USD852837S1 (en) | 2017-06-16 | 2019-07-02 | Bigfoot Biomedical, Inc. | Display screen with graphical user interface for closed-loop medication delivery |
USD839294S1 (en) | 2017-06-16 | 2019-01-29 | Bigfoot Biomedical, Inc. | Display screen with graphical user interface for closed-loop medication delivery |
US11389088B2 (en) | 2017-07-13 | 2022-07-19 | Bigfoot Biomedical, Inc. | Multi-scale display of blood glucose information |
USD863343S1 (en) | 2017-09-27 | 2019-10-15 | Bigfoot Biomedical, Inc. | Display screen or portion thereof with graphical user interface associated with insulin delivery |
US20190311798A1 (en) * | 2018-04-10 | 2019-10-10 | Sutter Health | Computing Devices with Improved User Interfaces for Applications |
CN112368037A (en) * | 2018-08-20 | 2021-02-12 | 深圳迈瑞科技有限公司 | Monitoring information output method, infusion pump, display device and storage medium |
WO2020037471A1 (en) * | 2018-08-20 | 2020-02-27 | 深圳迈瑞科技有限公司 | Monitoring information output method, infusion pumps, display device, and storage medium |
US11789962B1 (en) * | 2020-02-07 | 2023-10-17 | Hitps Llc | Systems and methods for interaction between multiple computing devices to process data records |
Also Published As
Publication number | Publication date |
---|---|
US12115339B2 (en) | 2024-10-15 |
US20230005588A1 (en) | 2023-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US12115339B2 (en) | Interactive guidance for medical devices | |
US12059552B2 (en) | Configurable target glucose values | |
US11367528B2 (en) | Proactive image-based infusion device delivery adjustments | |
US11826548B2 (en) | Efficient confirmation of blood glucose measurements | |
EP3796330B1 (en) | Methods for operating mode transitions and related infusion devices and systems | |
US11872372B2 (en) | Identification of sites for sensing arrangements | |
US11712520B2 (en) | Infusion devices and related meal bolus adjustment methods | |
CN107787232B (en) | Infusion device for treatment recommendation | |
US20220347381A1 (en) | Extensible infusion devices and related methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MEDTRONIC MINIMED, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SOKOLOVSKYY, DMYTRO Y.;COUMBE, SHAWN A.;MILLER, MARIA DIANA;REEL/FRAME:040435/0093 Effective date: 20161121 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |